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Abstract
SEX-DEPENDENT ROLE OF INTERLEUKIN-1 SIGNALING IN EMOTIONAL AND
COGNITIVE BEHAVIORS IN MICE: PHENOTYPING MALE AND FEMALE 1L1-R1
NULL MUTANT MICE
by
Jennifer A. Johnson

Adviser: Adjunct Associate Professor Susan D. Croll
IL1-R1 null mutant mice (IL1-R1 KO) have reduced signaling in the interleukin-1 (IL-1)
pathway, making them a convenient model for testing the importance of IL-1 in either the
development or maintenance of mouse behaviors. Prior research has revealed impaired cognitive
and emotional processes in adult male IL1-R1 KO mice, including impaired spatial learning and
memory and decreased anxiety with associated impairments in hippocampal cell proliferation
and signal transmission. The current studies explored the neuroanatomy and behavioral
phenotype of both male and female IL1-R1 KO mice. An array of behavioral tests was
administered, including retesting at an older age for cognitive and emotional behaviors. Animals
were sacrificed and their brains were measured for neuroanatomical abnormalities, cell
population densities, and vascular proliferation. The results were consistent with prior findings
of impaired spatial learning and memory performance for male IL1-R1 KO animals, as well as
reduced anxiety-type responses in multiple behavioral tests. Female IL1-R1 KO mice were less
affected, and showed no behavioral impairment in the Morris Water Maze (MWM). The
findings also revealed an increased depressive-type behavior in the Porsolt Forced-Swim test
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(FST), but only in female IL1-R1 KO animals. All animals were retested at a later age in the
MWM to determine if the observed sex-based differences in impaired spatial learning and
memory would persist or increase with age. We found impaired spatial memory performance for
aged IL1-R1 KO animals, and although older male KOs showed poorer performance in the
MWM than female KOs, the difference between sexes no longer achieved statistical significance.
Neuroanatomical evaluation revealed no gross differences in cortical or hippocampal structure.
However, IL1-R1 KO animals had significantly reduced vascular investment in the hippocampal
region, a finding that significantly correlated with impaired spatial memory performance in older
animals. These findings suggest that disruption of normal IL-1 activity can influence vascular
density in the hippocampus and also alter hippocampally-mediated behavior, including spatial
learning and memory. The findings also reveal sex-dependency of these effects, suggesting the
possibility that male and female animals suffer different behavioral consequences of IL-1
signaling deficiency.
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CHAPTER 1: GENERAL INTRODUCTION
Interleukin-1
Interleukin-1 (IL-1) is a pro-inflammatory cytokine important for the physiological
immune response. Cytokines like IL-1 are proteins important in immune functions, but many
have also been found to be important in the signaling between neurons and glial cells of the
central nervous system. Many cytokines, including IL-1, are also important for embryonic
development and neuro-developmental processes. The two forms of IL-1, IL-1α and IL-1β, exert
their effects on Type I (IL-1R1) and Type II (IL-1R2) receptors. Generally, IL-1α has a higher
affinity to bind with IL-1R1, while IL-1β has a higher affinity for IL1-R2, though both IL-1α and
IL-1β will bind to either receptor. The IL1-R2 receptor acts as a decoy receptor, producing no
signal when either IL-1α or IL-1β is present. In addition, IL1-R1 antagonist (IL-1ra), a naturally
occurring antagonist, has a very strong affinity for IL1-R1, but does not transduce a signal at the
IL1-R1 receptor. The presence of IL-1ra and the decoy receptor function of IL1-R2 mean the
primary signaling pathway of the IL-1 system is associated with binding of IL-1β to IL1-R1 (see
Dinarello, 1997, for a review).
IL-1 activity is diffusely distributed throughout the central nervous system, with
especially high expression in regions associated with neurogenesis and/or plasticity.
Specifically, IL1-R1 is highly concentrated in the olfactory bulb, frontal cortex, hippocampus,
thalamus, hypothalamus, and cerebellum (Gayle, Ilyin, & Plata-Salamán, 1997). It is widely
accepted that IL-1 is highly active in the central nervous system, with consistent findings of
especially high expression in the hippocampus (Ross, Allan, Rothwell, & Verkhratsky, 2003),
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which has been associated with neuroplasticity and learning and memory processes (Moore, Wu,
Shaftel, Graham, & O’Banion, 2009; Murray & Lynch, 1998).
Normally, only trace amounts of IL-1β are found in the adult central nervous system
(CNS). IL-1β levels are found to spike with the presence of a pathogen (Fontana, Weber, &
Dayer, 1984) or CNS insult (Giulian, Chen, Ingeman, George, & Noponen, 1989). IL-1 activity
increases with many different pathological conditions, including injuries to the central nervous
system, as well as local or peripheral injuries, and has been associated with activation of glial
cells, including both astrocytes and microglia (the brain’s specialized resident macrophages) (see
Basu, Krady, & Levinson, 2004, for a review). The purpose of IL-1 activation in the injured
central nervous system is under dispute (Gosselin & Rivest, 2007). Early on, evidence indicated
IL-1 was important in the healing process, through the activation of glial cells, neuronal
sprouting, promotion of vascularization, and production of neurotrophic factors. More recently,
however, evidence for other more constitutive effects of IL-1 has accumulated. This evidence
will be described at length in later sections of this review.
In the periphery, IL-1β is secreted into the bloodstream, where it triggers fever
production through activation of the hypothalamic vascular network, as well as activation of
endothelial receptors throughout the body (Schöbitz, Reul, & Holsboer, 1994). Because of its
strong role in the immune response, it is not surprising that IL-1 has been found to play an
important role in inflammatory and autoimmune disorders (see Blanco, Palucka, Pascual, &
Banchereau, 2008, for a review), including gout and rheumatoid arthritis (Pope & Tschopp,
2007; Brennan & McInnes, 2008; & García-De La Torre & Nava-Zavala, 2009). However, IL-1
has also been associated with the promotion of neuronal damage in the acute stages of injury,
perhaps via its promotion of free radicals (Betz, Schielke, & Yang, 1996). In addition, by
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upregulating glial cell activity, IL-1 is also implicated in neuro-degenerative diseases (Giulian,
Vaca, & Johnson, 1988). One example is Alzheimer’s disease (AD), in which microglia are
found to surround amyloid plaques, and possibly play a role in the development of the plaques,
or at least in the immune response to the plaques (Shaftel, Griffin, & O’Banion, 2008). Via these
same mechanisms, IL-1 has also been suggested as a player in demyelinating diseases (see
Viviani, Gardoni, & Marinovich, 2007).
IL-1 is an important player in a cascade of immunological processes associated with
infection and the fever response (see Basu et al., 2004, for a review). During the peripheral
immune response, sentinel cells (macrophages, leukocytes, and mast cells) detect a pathogen,
signaling the release of cytokines that are carried to the brain via the bloodstream or reach the
brain indirectly via nerves (e.g., the vagus nerve) (Gabay, Smith, Eidlen, & Arend, 1997).
Several cytokines are known to trigger the metabolic and behavioral changes seen in the sickness
response, promoting disease resistance and recovery processes (see Tizard, 2008, for a review).
The biggest players in this cytokine response include IL-1β, tumor necrosis factor alpha (TNFα), and Interleukin-6 (IL-6). Additional cytokines have also been associated with the sickness
response, including Interleukin-18 (IL-18), Interleukin-33 (IL-33), high mobility group box
protein-1 (HMGB1), and Interferon-γ (IFN-γ). Thus, while the current paper focuses specifically
on IL-1, it is recognized that it is only one element in a very complex innate immune system.
Interleukin-1 and Sickness Behavior
As a proinflammatory cytokine, IL-1 is known to play an important role in the normal
immune response and related “sickness behavior.” During the normal immune response to
pathogens people will develop a fever and associated transient changes in behavior, mood, and
cognition. The typical sickness response includes an anorexic response, with reduced feeding
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and drinking as well as weight loss (Szelenyi & Szekely, 2004). Individuals will also experience
a general malaise and depression, accompanied by social withdrawal, decreased sexual activity,
anhedonia, fatigue, and changes in sleep, including a marked increase in slow-wave sleep
activity (Vollmer-Conna, et al., 2004; Krueger, 2008; Eisenberger, Inagaki, Mashal, & Irwin,
2010). In some cases of sickness behavior, people may experience enhanced perception of pain
and feelings of muscle weakness. In addition to these physical and emotional symptoms,
sickness behavior may also include cognitive changes, including impaired learning and difficulty
concentrating (see McAfoose & Baune, 2009, for a review).
It is hypothesized that both the thermoregulatory changes and the related changes in
behavior have a biological value, by promoting the conservation of limited physiological
resources and recovery of energy homeostasis (Engel & Schmale, 1972; Dantzer, 2001).
Because of the complexity of the immune response, the changes can be transient or have a more
long-term systemic effect, especially for the more severe emotional and cognitive changes
(Szelenyi & Szekely, 2004).
While widely recognized, systematic research into the wide array of motivational, motor,
emotional, and cognitive behavioral changes associated with the febrile response are limited. In
fact, most studies of multi-domain changes in humans with the sickness response have focused
on specific clinical conditions and related treatments that regulate cytokine activity, but have
failed to either focus on a broad array of symptoms or to link the changes directly to measured
cytokine activity. For example, Santoro, Tomita, and Larson (2007) focused on emotional
changes (increased depression and anhedonia) and cognitive symptoms (impaired learning, poor
concentration, and decreased attention) that systematically fluctuated with periods of illness
flares in patients with systematic lupus erythematosus (SLE), but failed to document the direct
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correlation to cytokine levels or other changes in sickness behavior. Also, the connection
between the proinflammatory response to chemotherapy and cognitive impairments has been
anecdotally documented, and recently validated in a clinical study (Myers, Sousa, & Donovan,
2010).
A cluster of disorders known as CAPS (cryopyrin-associated periodic syndrome) has
provided a strong link between IL-1 activity and sickness behavior. CAPS includes three
overlapping inherited disorders, each of which involves chronic of recurrent systematic
neuroinflammation of the skin, muscles, skeleton, joints, eyes and CNS (see Giat & Lidar, 2014,
for a review). Patients with the most severe of the CAPS disorders, neonatal onset multisystem
inflammatory disorder (NOMID), will also frequently develop hydrocephalus or brain atrophy,
accompanied by sensorineuroal hearing loss and mental retardation. Recently, three different
anti-IL-1 treatments have been developed for the alleviation and even complete remediation of
symptoms, with varying results for patients with the more severe NOMID condition (GoldbachMansky, 2011; Neven et al., 2009).
Finally, studies of a common anti-inflammatory treatment for multiple sclerosis (MS)
have shown in one instance the induction of a physical sickness response without emotional or
cognitive symptoms in healthy individuals injected with Interferon-β-1b (IFN-β-1b) (Exton,
Basse, Pithan, & Goebel, 2002), while MS patients on a regimen of weekly treatments of
Interferon-β-1a (IFN-β-1a) were found to reduce their rate of progression of cognitive
impairments within two years (Patti et al., 2009).
Notably, most clinical studies have focused on conditions that result in a long-term
inflammatory state that can result in neuronal damage, which is not typically found in the acute
inflammatory response (Teeling & Perry, 2009). More comprehensive studies of acute and
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systemic sickness behavior have been conducted in animal populations, typically inducing a
sickness response either with central or peripheral administration of a pathogen that produces a
cytokine response or with direct injections of cytokines. Injections of lipopolysaccharide (LPS),
even at very low doses, produce a series of behavioral changes, including reductions in
locomotion, grooming behavior, rearing, and social interactions in rats (Bison, Carboni, Arban,
Gerrard, & Razzoli, 2009). The array of behavioral changes associated with cytokine activity is
broad. Peripheral injections of IL-1β or LPS elicit an anorexic response, accompanied by weight
loss within a day of injection (Bison et al., 2009; Harden et al., 2011). In addition, animals are
found to develop a conditioned taste aversion with IL-1 injections (Tazi, Dantzer, Crestani, & Le
Moal, 1988), while blocking IL-1 receptors prevents the anorexic response to LPS injections
(Rothwell & Luheshi, 2000).
Fatigue is typically measured in animal research by a decrease in locomotor, grooming,
and exploratory behaviors, as well as an increase in sleep activity. Injections of IL-1β not only
increase sleep activity, but specifically lead to increased proportion of sleep time spent in nonREM sleep (Yasuda, Yoshida, Garcia-Garcia, Kay, & Krueger, 2005), though very high doses of
IL-1β can decrease sleep activity (Opp, Obal, & Krueger, 1991). Conversely, mice treated with
IL-1ra, blocking IL-1β activity, were resistant to development of a fever or sickness behaviors
when later injected with IL-1β (Cremona, Goujon, Kelley, Dantzer, & Parnet, 1998). Similarly,
IL1-R1 knock out (KO) mice injected with turpentine fail to have the typical acute phase
response to inflammation, including reduced lethargy, a loss of the anorexic response, and
preserved body weight (Leon, Conn, Glaccum, & Kluger, 1996). In addition, adult female IL1R1 KO animals have been found to have slightly altered circadian rhythms, with slightly reduced
activity during light cycles and slightly increased activity during dark cycles (Murray, Obiang,
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Bannerman, & Cunningham, 2013). Unfortunately, male animals were not included in this
measure. IL-1α/β KO mice have also been shown to lack a typical febrile response and related
decreases in locomotion following a surgical procedure that induced an HPA (HypothalamicPituitary-Adrenal) stress response (Furuzawa, Kuwuhara, Ishii, Iwakura, & Tsubone, 2002).
The amelioration of the sickness response is not specific to IL-1. This effect can occur
when either IL-6 or IL-1β activity is blocked (Harden et al., 2011). Specifically, blocking the
activity of IL-6 prevented an increase in body temperature (fever response), along with an early
reduction in food intake and more long-term effects (24 hours) on immobility. On the other
hand, blocking IL-1β activity only mildly reduced the fever response, but had a significant
impact on sickness behaviors. In addition, blocking one cytokine or the other failed to affect the
expression of their counterpart, indicating that while both cytokines are involved in the
production of a fever and related sickness behavior, they are not dependent on one another for
normal levels of activity.
In addition, pathogenic stimuli cause an activation of multiple different actions, as
evidenced by the separate contributions of IL-6 and IL-1 on sickness behavior. Thus, it is not
surprising that research findings on fever induction and sickness behavior have been
contradictory. In particular the effects of isolated injection of IL-1β will differ from effects
associated with a more complex immune response following a natural pathogen, such as LPS.
Bluthé et al. (2000) found that IL1-R1 KO mice had a reduced sickness behavior response to
both central and peripheral injections of IL-1β, but not to centrally administered LPS. The
difference in these effects was found to potentially depend on the upregulation of TNF-α with
LPS injections, which effectively replaced the deficient IL-β activity, as evidenced by a similar
reduction in sickness behavior when animals were given a TNF-α blocking agent.
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The specific role of IL-1β in the inflammatory response associated with fever and
sickness has also been found to vary over time, with evidence for two phases of IL-1β induction
(Konsman, Kelley, & Dantzer, 1999). In the acute phase, approximately two to four hours after
peripheral LPS injections, IL-1β production peaks in the circumventricular organs, choroid
plexus, and cerebral vasculature. Approximately eight to twelve hours after LPS injections, a
second peak occurs, involving microglial cells. The difference in these two phases of IL-1β
upregulation has been hypothesized to lead to an initial sickness behavior in the early stages of
infection, and depressive symptoms in later stages of infection and chronic inflammatory
conditions (Dantzer, 2001). These findings are important for animal studies of sickness
behavior, as there is a large degree of overlap in behavioral patterns between the lethargy
associated with illness and the malaise associated with depression, which is frequently
experienced with a prolonged illness. Support for this theory comes from findings that LPS
injections produce a reduction in mobility two hours later, which coincides with increases in IL1β, IL-6, and TNF-α levels in the hippocampus, striatum, and frontal cortex, while at the 24-hour
mark, animals instead show a depressive response in the Porsolt forced-swim test (FST), which
is accompanied by a an even greater increase in IL-1β levels, centrally, while IL-6 and TNF-α
levels return to normal levels (Bay-Richter, Janelidze, Hallberg, & Brundin, 2011).
Interleukin-1 and Stress
During an acute stressful event the HPA (Hypothalamic-Pituitary-Adrenal) axis is
activated, starting with the hypothalamus-triggered release of ACTH (adrenocorticotropic
hormone) from the pituitary gland that stimulates corticosteroid synthesis and secretion from the
adrenal gland. Glucocorticoids, in turn, travel back to the hypothalamus and pituitary gland and
suppress the production of ACTH (see Laugero, 2001, for a review). This negative feedback
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loop is important for the regulation of the acute stress response. Glucocorticoid receptors are
also found in the hippocampus, as well as the septum, amygdala, and other cortical and
subcortical regions (Reul & de Kloet, 1985; van Eekelen, Kiss, Westphal, & de Kloet, 1987;
Joëls, 2001). Thus, the stress response can have a widespread effect within the CNS.
Cortisol, a glucocorticoid, is a major stress hormone that can be harmful in severe stress
or chronic stress conditions, with evidence of stress-induced atrophy in the hippocampus in both
humans and animals (see Bremner, 2006, for a review). This atrophy can, in turn, affect memory
performance. The link between stress, anxiety, and cytokine activity is well established in
clinical and non-clinical populations. Individuals in good health undergoing a significant
emotional stressor will frequently report depressive symptoms and anxiety, which are associated
with a proinflammatory response. For example, Maes et al. (1998) found medical students had
increased levels of multiple proinflammatory cytokines the day prior to taking an academic
exam, and individuals who reported the most severe anxiety symptoms were found to have the
highest levels of proinflammatory cytokines. It has even been found that individuals undergoing
a mild cognitive stressor (e.g., mirror drawing and color-word interference Stroop tasks) had an
increase in IL-1β gene expression, and this increase correlated with measures of sympathetic
nervous system activity, including increased blood pressure and heart rate (Brydon et al., 2005).
Given that HPA axis activation leads to increased sympathetic arousal, including
increased blood pressure, it is not surprising that individuals with high levels of chronic
psychosocial stress are at an increased risk for coronary heart disease. These high-risk
populations are also found to have a systemic inflammatory condition (Kuper, Marmot, &
Hemingway, 2002; Shen, Chen, & Ge, 2004). For example, von Känel, Bellingrath, and
Kudielka (2009) found teachers reporting career burnout had relatively high levels of
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proinflammatory cytokines, including a surge in TNFα levels. This population was also found to
be at a higher risk for developing cardiovascular disease. Similarly, post-combat post-traumatic
stress disorder (PTSD) patients were found to have higher IL-1β serum levels that correlated
with the duration, but not severity, of anxiety symptoms (Spivak et al., 1997).
While the HPA axis plays a role in the suppression of the immune system, the immune
response can influence HPA activity. For example, IL-1β stimulates the release of corticotropicreleasing factor (CRF) by the hypothalamus, which, via ACTH, induces the secretion of
glucocorticoids from the adrenal glands (see Laugero, 2001, for a review). This feedback loop
between HPA activity and cytokine activity has also been associated with changes in emotional
behavior. Mice injected with IL-1 show activation of the HPA axis, which is associated with
increases in noradrenaline and serotonin (5-HT), both of which are implicated in depressive and
anxiety conditions (Dunn, 2000). The relationship between IL-1β and HPA axis activation is
very complex, with the time course and overall impact varying with the types of injections given
(intraperitoneal vs. subcutaneous) (Dunn, 2000), or the type of anxiety-provoking stimulus that is
used (Plata-Salamán et al., 2000).
Multiple models have been developed to induce a stress response in rodents, eliciting
behaviors that are categorized as either depressive or anxiety-like. The distinctions between
anxiety and depression are especially important in animal models of behavior. Cryan and
Holmes (2005) propose that while there is a large degree of heterogeneity for depressive and
anxiety conditions, behavioral testing has developed to focus on the differences in these
conditions. Generally, testing of depressive behavior focuses on coping, learned helplessness,
anhedonia, and social interactions. Anxiety tests tend to focus more on approach and exploratory
drives. Frequently, both depressive and anxiety behavioral testing will employ the use of a stress
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stimulus, which can have effects on both depressive and anxiety-type behaviors. The validity of
these different stress-based tests in eliciting anxiety and or depressive responses has been
confirmed repeatedly with the alteration of responses following the introduction of anxiolytic or
antidepressant medications (see Belzung & Griebel, 2001, and Cryan & Holmes, 2005, for
reviews).
Early tests of anxiety in response to a stressful stimulus were based on conditioning
paradigms, in which animals were conditioned to expect a fearful and often painful stimulus
(e.g., foot-shock). Another set of tests measure exploratory behavior in novel settings, such as
the elevated plus maze in which an animal is placed on a cross shaped platform with two arms
that are closed and an opposing set of exposed arms (Belzung & Griebel, 2001). Anxious
animals will typically avoid entering the open, exposed arms. Similarly, in the open field test
animals are placed in a large grid with walls on all four sides, and animals high in anxiety will
tend to spend their time exploring along the wall edges instead of entering the open, exposed
center of the grid.
Additional tests measure more trait-based anxiety, as opposed to an acute stress response.
In the marble burying task, animals are placed in a cage with several marbles placed on top of
the bedding (Nicolas, Kolb, & Prinssen, 2006). Animals with a trait anxiety similar to that of
patients with Obsessive Compulsive Disorder (OCD) are found to bury the marbles in the
bedding. Tests of social neophobia (avoidance of an unfamiliar, non-threatening animal) are also
thought to measure more chronic trait-type anxiety (Belzung & Griebel, 2001).
Finally, another set of tests look at the effects of more chronic stressful conditions and
effects on behavior. In the chronic unpredictable stress (CUS) paradigm, animals are exposed to
alternating mild (e.g., wet bedding or tilted cage) or moderate (e.g., predator in nearby cage)
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stressors over the course of several weeks, followed by testing of anxiety-like behavior (Bondi,
Rodriguez, Gould, Frazer, & Morilak, 2008). More recently, in an attempt to develop a more
ecologically valid model of chronic stress exposure, researchers have employed a chronic social
defeat test, in which animals are paired repeatedly with another animal, allowing for the natural
response of dominant and aggressive behavior (Denmark et al, 2010). After repeated
experiences of social defeat, animals are then tested in measures of anxiety-type behavior.
Much of the research into the relationship between IL-1β and anxiety-type responses to
stressful experiences has employed the use of the elevated plus maze and open field test.
Animals injected with IL-1β are found to have anxiety-type responses, similar to stress exposure.
Swiergiel and Dunn (2007) injected animals with varying doses of LPS and found a dosedependent relationship, where higher levels of IL-1β were associated with a reduction of entries
into the open arms of the elevated plus maze and a reduction of entries into the center of the grid
in an open field test, suggesting an increased level of anxiety. However, they also found an
overall reduction in mobility, making it likely that they were not only measuring anxiety, but
also sickness behavior. Koo and Duman (2009) also found an increase in anxiety-type behavior
in rats injected with IL-1β, with fewer open arm entries into the elevated plus maze, but in the
presence of reduced mobility. In order to better study the effects of IL-1β without the
confounding sickness behavior, Koo and Duman also tested male IL-1R1 KO mice, which had a
reduced anxiety-type behavioral response. These KO animals showed increased open-arm
entries into the elevated plus maze, as well as an increased latency to enter the dark region in a
light-dark chamber. Similarly, Murray et al. (2013) found a reduced-anxiety type response for
both male and female adult IL1-R1 KO mice in the elevated plus maze, with increased time
spent in the open arms, but no effect for the total number of open-arm entries.
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Animals exposed to different acute and repeatable physical and environmental stressors
are found to have increased corticosterone levels, which correlate with increased concentrations
of IL-1β in the hippocampus (Murray & Lynch, 1998). However, the reaction to specific
stressors varies, with evidence that some stressors, such as shock and immobilization, produced
activation of IL-1β activity in limbic regions, while other stressors, such as predator exposure
and FST, do not (Plata-Salamán et al., 2000). In addition, the expression of IL-1β in the
hippocampus and amygdala associated with stress conditions is age-dependent. BadowskaSzalewska et al. (2009) found levels of IL-1β increased in the amygdala and hippocampus for
juvenile animals exposed to stress (both open field and FST paradigms), for both acute and
chronic exposures, while aged animals only showed an effect for chronic conditions, possibly
reflecting a learned compensatory behavioral response that prevents the neuroimmune response
to acute conditions in aged populations, or an overall drop in the immune response in aging.
Similarly, sex-differences have been observed. For example, Yee and Prendergast (2010)
injected male and female rats with LPS and found typical sickness behaviors (decreased feeding
and locomotor activity) for both sexes, but the response to particular stressors differed by sex.
Males were found to have exacerbated symptoms with social deprivation (housed singly), while
group housing exacerbated females’ symptoms. Thus, the nature of stressors can differ by sex.
Interleukin-1 and Depression
The overlap between sickness behavior and depressive symptoms indicates a potential
role for IL-1 in the regulation of depressive disorders. Adult depressive disorders are classified
into sets of different syndromes in the DSM-V (American Psychiatric Association, 2013), each
with a unique set of diagnostic criteria. Included among the depressive conditions are Major
Depressive Disorder (MDD) and Persistent Depressive Disorder (PDD). MDD requires the
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presence of major depressive episode for at least two weeks, in which an individual experiences
depressed mood or anhedonia, as well as additional somatic symptoms (changes in eating or
sleep, psychomotor agitation, or fatigue), and/or emotional or cognitive symptoms (feelings of
guilt or worthlessness, difficulty concentrating, or thoughts of death). PDD represents a more
chronic condition, in which an individual experiences major or mild depressive symptoms over
the course of at least two years. The distinction between MDD and PDD primarily relates to the
duration of depressive symptoms, and individuals with a PDD may experience major depressive
episodes.
Both MDD and PDD can develop during adolescence or adulthood, but more severe
symptoms and higher rates of prevalence are associated with younger ages, with a mean age of
onset for initial major depressive episode in the mid- to late-twenties. A peak of depression risk
starts in adolescence rises into the mid-twenties, and declines thereafter (Andrade et al., 2003).
The prevalence of depression in later years of life is unclear. In some ways, the aged are seen as
vulnerable individuals, with increased risks for reactive depression, such as loss of autonomy and
major health concerns (Schulz, Heckhausen, & O’Brien, 1994), but the elderly are also seen as
more resilient and better prepared to face stressors and less likely to develop reactive depression
(Baltes & Baltes, 1990). This dichotomy of theories is reflected in research findings that have
found both higher (i.e., Kanowski, 1994) and lower (Henderson et al., 1998) rates of depression
among aged populations when compared to rates in the overall or younger populations.
The mixed findings in research in aging may reflect research limitations associated with
the aging population, with clear cohort effects and issues of selective survival of people who are
not prone to depressive conditions (see Rothermund & Brandtstädter, 2003, for a review). More
recently, research that has attempted to statistically account for these and other confounds has
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pointed to a pattern of increased risk for depression, but only among the oldest aged populations
(Teachman, 2006). This suggests a curvilinear function of prevalence over the lifespan, with a
decline in middle adulthood years, and then a second peak in the older aged, especially over 80.
In addition, when researchers have changed the focus of their criteria for depressive conditions to
include not just individuals classified with clinical disorders (i.e., switching a focus from
categorical criteria of depressive syndromes to continual dimensional traits of depressive
symptoms), the increase in depressive-type conditions among the aged is strongly evident, with
increases starting as early as the mid-50s and having a sharp incline in the late 80s (see metaanalytic review of studies by Snowdon, 2001). This, in part, may be explained by differences in
reporting among different age groups, in which individuals over the age of 65 are less likely to
report sadness than younger individuals (Gallo, Anthony, & Muthén, 1994), which has been
replicated over several years, implying the difference is age-related and not a cohort effect
(Gallo, Rabins, & Anthony, 1999). Thus, as people reach an older age, there appears to be a
general increase in the risk for the development of depressive conditions, although the nature of
later life depression may differ from earlier developed forms of the condition. These differences
may also reflect changes in the neuroimmunological status of the aged population (to be
discussed below), with specific contributions of changes in IL-1 activity.
Research in the field of depression has recently highlighted the suggestion of a unique
depressive condition found in the aged, with a pattern of symptoms that reflect underlying agerelated changes in the central nervous system and age-typical changes in lifestyle and life
stressors. Generally, when compared to younger adults, older depressed individuals will exhibit
greater anhedonia than sadness, and prominent somatic complaints, including sleep and eating
disturbances, fatigue, and psychomotor agitation (Holland, Schutte, Brennan, & Moos, 2010).
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Despite a decrease in reporting feelings of sadness, older-aged depressed populations have also
been found to have more thoughts of death and suicide (Conwell, 2009). The Center for Disease
Control and Prevention statistics reveal that white males over the age 85 had the highest suicide
rate among all U.S. populations between 2002 and 2006 (Centers for Disease Control, 2009).
The pattern of symptoms found in late life depression fit a subtype identified by
Abramson, Metalsky, and Alloy (1989; later validated by Joiner et al., 2001) as a hopelessness
subtype of depression that presents with suicidal ideation, psychomotor agitation, fatigue, and
negative cognitive evaluations of the self and the world. Because of the high prevalence of
somatic complaints in late-life depression, including fatigue, sleep, and psychomotor
disturbances, Holland et al. (2010) propose later in life depression is caused by disruptions to the
central nervous system that result in overlapping disruptions to biological systems, affecting
appetite, sleep, and sex-drive, leading to in an overall feeling of a decline in well-being.
In essence, later-life depression carries many of the symptoms associated with the
sickness response reviewed previously. Alexopoulos and Kelly (2009) attribute these central
nervous changes to changes in the cerebrovascular system, supported by the findings of Bunce,
Handley, and Gaines (2008) who found vascular changes and hypofrontality in older adults who
experienced depression. Additional research has found neuroanatomical correlates (Kumar, Jin,
Bilker, Udupa, & Gottlieb, 1998) and neurochemical changes (see Gareri, de Fazio, & de Sarro,
2002, for a review) associated with late life depression. In addition, there is clear evidence of an
enhanced immune response in the aged that predisposes this population to both depression and
vascular disease (Mast et al., 2008).
With the perspective that late life depression may be a different type of depressive
condition from early-adulthood and adolescent onset conditions, one must also consider the large
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degree of variability among the elderly and different depressive conditions. Weber et al. (2009)
has shown among the elderly with an earlier onset condition (i.e. developed depressive condition
in their early or middle adulthood years that persevered into late adulthood) are distinct from
individuals who had their initial onset of depression after the age of 60. Specifically, they found
that individuals with earlier onset conditions had spared brain volume, showed no significant
vascular changes, and also had preserved cognitive functions, unlike individuals with later onset
conditions. Weber also reports individuals who experience an earlier onset depressive condition
are more likely to have depressive conditions that reflect a personality vulnerability, with higher
levels of neuroticism and decreased extraversion that put them at greater risk of responding to
typical late in life psychosocial stressors.
In addition to the distinction between depressed elderly patients with early versus later
onsets of the condition, there is a growing effort to look at specific forms of depression
associated with aging, including vascular depression and age-related neurocognitive disorders.
Depression is a known correlate of cardiac disease, especially in older adult populations, leading
to the conceptualization of a medically related depression condition referred to as vascular
depression, which has a strong relationship to sickness behavior (Korczyn & Halperin, 2009).
Various studies have looked at this relationship in both prospective (depression symptoms
anticipating cerebrovascular or cardiac conditions, e.g., Vinkers, Stek, Gussekloo, van der Mast,
& Westendorp, 2004) and reactive (depression following cerebrovascular or cardiac conditions,
e.g., Bour et al., 2009) research paradigms. By looking at hospitalized cardiac patients,
researchers have identified a profile of symptoms classified as vascular depression, with
pronounced somatic complaints, anhedonia and psychomotor retardation, and cognitive
impairments (Alexopoulos et al., 1997). These patients were also found to experience less guilt
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and have reduced insight into the severity of their condition. However prospective studies of
patients with this profile do not predict future cardiac conditions, with only cognitive difficulties
being a reliable predictor of a first cardiac event within the next eight years (Naarding,
Veereschild, Bremmer, Deeg, & Beekman, 2009).
The anhedonia and psychomotor retardation symptoms of vascular depression probably
reflect diffuse or localized white matter lesions that can be found in prefrontal regions (Murphy
et al., 2007), as well within the nigrostriatal dopaminergic pathway or the prefrontal-subcortical
circuits (Court & Perry, 2003). Attention and other executive deficits have been associated with
lesions of the thalamus, periventricular lesions, and small-vessel ischemia (Taylor, Aizenstein, &
Alexopoulos, 2013). There is no clear localization of vascular depression symptoms to a
particular neurological profile, but rather a complex network of cortical and subcortical
structures that may all contribute to a vulnerability to develop a vascular depressive condition
(Alexopolous et al., 1997). Thus, evidence supports a link between cardiovascular disease and
depression, with common mechanisms, and evidence that each can precede the other, but the
causal nature of this connection is tentative (Paz-Filho, Licinio, & Wong, 2010).
With the failure to find focal lesion patterns for vascular depression, research has instead
put a focus on degrees of neuropathology across diffuse brain regions. In one study, of the 52%
of post-stroke patients who developed depression, there was a significantly higher rate of
depression among those individuals with the larger lesions, with no clear pattern of lesion
localization (Nys et al., 2005). More recent research has particularly focused on non-localized
white matter lesions and overall volumetric losses. In one such study, such measures were able
to significantly predict depressive symptoms within three years, though the relationship was no
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longer significant when functional losses associated with disability were accounted for in a
regression model of depressive outcomes (Teodorczuk et al., 2010).
Recently, Taylor et al. (2013) proposed a model of vascular depression in which regional
changes in brain function are attributed to a remodeling of the vasculature due to disruption of
local fiber tracts and changes in functional connectivity between executive and affective centers
of the brain. These localized and connective disruptions reflect both white matter lesions as well
as general impairments in cerebral blood flow (cerebral hypoperfusion). Important to later
discussions in this review, they suggest that neuroinflammatory processes associated with aging
play a critical role in the regulation of this system.
Given the variability in the types of depression, causes, and sex- and age-based
differences, it is not surprising that several different neurotransmitter systems are found to play a
significant role, including serotonergic, dopaminergic, noradrenergic, cholinergic, GABAergic,
and peptidergic functions (see Krishnan & Nestler, 2008, for a review). In addition, activation of
the HPA Axis is found in a large proportion of patients with depressive conditions (Manji,
Drevets, & Charney, 2001), linking depression to stress and anxiety, as well as
neuroimmunological activity, including the upregulation of IL-1β activity.
As described above, IL-1 and other cytokines are associated with sickness behavior,
which is characterized by symptoms that are common in depressed populations. Medical
patients with immune abnormalities (e.g., rheumatoid arthritis and allergies) are found to be at
risk for the development of depression following the immunological response (Whalley, Jacobs,
& Hyland, 2007), and patients undergoing cytokine treatment for medical conditions (e.g.,
multiple sclerosis, leukemia, and various forms of cancer) exhibit sickness behavior along with
depression (Valentine, Meyers, Kling, Richelson, & Hauser, 1998; Goeb et al., 2006). However,

20
evidence is mixed, with some studies of clinical populations finding no clear association between
cytokine activity and depression, and confounding results because of psychologically lifechanging events coincident with treatments that can also explain the onset of depressive
symptoms (see de Beaurepaire, 2002, for a review). Individuals with clinical depressive
conditions are found to have a systemic pro-inflammatory state, in both major (Owen, Eccleston,
Ferrier, & Young, 2001) and mild (Maes, Bosmans, Meltzer, Scharpé, & Suy, 1993) depressive
conditions, but again results are mixed and clearly not all depressed individuals show a proinflammatory condition (Zorilla et al., 2001). The use of anti-inflammatory pharmacological
treatments for depression has also been inconsistent (see Miller, Maletic, & Raison, 2009, for a
review). However, these inconsistencies may be significant in understanding cases of treatmentresistant MDD, as some of these cases may be attributed to a variation in the IL-1β gene. For
example, Baune et al. (2010) found MDD patients who had the rs114643 variant of the IL-1β
gene were more likely to experience a period of non-remission over a six-week period of
antidepressant treatment.
While sickness behavior and depression have similar presentations, with behavioral
patterns of reduced activity, decreased sexual behavior, decreased appetite, sleep disturbances,
and reduced motivation, they are distinct conditions. In sickness behavior there is an inciting
illness with a febrile response which, combined with the energy conserving function, is thought
to have an adaptive value to allow for healing and fighting off infections (Kent, Bluthé, Kelley,
& Dantzer, 1992). Clinical depression is not usually associated with a change in body
temperature, though some depressed patients experience a relative increase in body temperature
when sleeping that disappears when symptoms subside (Duncan, 1996). In addition, although it
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has been argued that there is an adaptive value to depressive conditions, such benefits are unclear
and controversial (McLoughlin, 2002).
Research on depression in animals is often limited to sickness behaviors. However, using
specialized protocols, researchers are able to isolate out depressive-type behaviors for general
sickness responses (see Frazer & Morilak, 2005, and Gardier et al., 2009, for reviews). For
example, low-dosage injections of cytokines can produce a depressive response without inducing
a hypothermic response or the complete array of sickness behaviors. Animals with genetic
mutations to alter cytokine activity are also employed, though there is always a concern with
mutant animal models that the targeted genetic mutations can have a broad impact on normal
development, possibly reducing the validity of the adult animal (Crnic, 1996).
Certain behavioral tests have been shown to selectively change with the application of
efficacious anti-depressant treatments, implying they are testing a depressive-type condition that
is distinct from other sickness- or anxiety-type behaviors (Kalueff & Tuohimaa, 2004). These
methods include the FST the tail-suspension test, and the inescapable shock test, based on
learned helplessness models of depression. In addition, the sucrose preference test, a model of
anhedonia, has also been shown to have predictive validity. In the FST animals are placed in a
pool of water for an extended period of time with no opportunity to escape and then are
reintroduced to the pool at a later time. Animals with a depressive-type response exhibit
immobility in the second trial, failing to engage in escape behaviors. A similar effect is
measured in the tail-suspension test in which an animal is suspended by the tail for an extended
period of time and the latency to discontinue escape behaviors is measured, again reflecting a
learned helplessness response. In the inescapable shock procedure, animals are given repeated
shocks (i.e., to the foot or tail), and then tested for conditioned fear responses and escape
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behavior following an escape training paradigm. The sucrose preference test relies on the
phenomenon that animals typically prefer a sucrose solution to water. However, when animals
are exposed to a chronic stressor, they fail to show a taste preference, modeling an anhedonic
loss of sensitivity to rewards. While all three methods test depressive-type behavior, it is likely
there is a difference between the learned helplessness-type effects, which are based on a loss of
avoidance behavior and the anhedonia-type effects, based on a loss of approach behavior (see
Jacobson, 2007, for a review).
There is mixed evidence for a learned helplessness type depressive response associated
with IL-1β activity. Rats exposed to an acute tail-shock stressor will develop a strong fear
conditioning response and have poor escape learning following the stressful event, but this effect
was reversed in animals administered IL-1ra, showing the importance of IL-1 for a typical
depressive-type response (Maier & Watkins, 1995). On the other hand, Koo and Duman (2009)
found that IL-1R1 KO mice were similar to controls in the FST, showing no difference in
learned helplessness type behavior with the constitutive prevention of IL-1R1 activity.
As mentioned above, there is an underlying difference between learned helplessness and
anhedonia models of depression, and though the evidence is mixed regarding the role of IL-1 for
learned helplessness type depression, there is very clear evidence for a link between IL-1 activity
and anhedonic depressive symptoms. Mice exposed to chronic mild stressors have a decreased
sucrose taste preference that correlates with changes in IL-1 activity in the hippocampus (Grippo,
Francis, Beltz, Felder, & Johnson, 2005), such that higher levels of IL-1 production are found in
animals with the greatest decline in sucrose preference. Goshen and Yirmiya (2009) found
similar changes in sucrose taste preference following CUS exposure, as well as in mice given a
chronic administration of IL-1 without a stress exposure, indicating IL-1 is a major component of
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the anhedonia effects of chronic stress. As further support, Goshen et al. (2008) found that IL1R1 KO mice as well as transgenic mice bred to overexpress IL-1Ra fail to show an anhedonic
response to CUS. Koo and Duman (2008) found both IL-1β injections and chronic stress
exposure can induce an anhedonic sucrose taste preference in rats, which was reversed with the
injection of an IL1-R1 antagonist. In addition, in a follow-up study, Koo and Duman (2009)
found a similar suppression of an anhedonic sucrose preference in IL1-R1 KO mice. On the other
hand, Murray et al. (2013) found no genotype effect for either female or male IL1-R1 KO
animals in a tail-shock CFC testing paradigm. Murray cites several reasons their results may
differ from those of other researchers, including the possibility in the differences in the
background strains of the IL1-R1 KO mice used in the Goshen study and the background for the
animals tested by the Koo and Murray laboratories, as well as differences in the background
strain of WT animal strains, in which the Goshen and Murray laboratories used the same
C57BL/6J controls while the Koo laboratory used a C57BL/6 control mouse that was bred from
a C57BL/6N line. It should also be noted Murray used animals from an in-house inbred colony,
while the other laboratories purchased their animals directly from Jackson Laboratories.
Just as sex and age are associated with variations in the expression of depression in
human clinical populations, similar effects are found in animal models of depression. Most
animal research on depression, and even on anxiety and sickness behavior, is conducted with
male-only populations. When female animals are included, some notable differences are found
for the role of cytokines in depressive-type behavior. Female rats are found to have reduced
sickness behaviors and reduced depressive-type learned helplessness behavior in the FST when
compared to males following LPS injections (Pitychoutis, Nakamura, Tsonis, & Papadopoulou-
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Daifoti, 2009). These differences coincided with an enhanced serotonergic response in female
animals, especially in the hippocampus and amygdala.
Age differences in depressive-type behavior are also seen for animals exposed to stress or
LPS injections. Rats introduced to either a mild (open field test) or moderate (FST) stressful
event have increased IL-1β activity, with a larger increase for aged (1-year-old) than juvenile (1month-old) animals (Badowska-Szalewska et al., 2009). In addition, aged mice injected with
LPS are found to have an exacerbated depressive-type response in both the tail-suspension and
FST tests, characterized by both an increased level of depressive response and an increased
duration of the response (Godbout et al., 2008). These findings are important in interpreting the
research discussed above showing an enhanced neuroinflammatory condition in aged
populations, along with the increased risk for depressive symptoms found in these populations.
Interleukin-1 and Cognitive Behavior
With IL-1 having such a widespread impact on neural functions and potential
involvement in neuro-degenerative diseases, it is not surprising that substantial evidence
implicates IL-1 in normal cognitive functioning, especially for learning and memory. Human
data about the role of IL-1 in cognitive performance has been mixed, with evidence of associated
impairments, or of a failure to find impairments in memory and other cognitive functions with
increased IL-1 activity (Brydon, Harrison, Walker, Steptoe, & Critchley, 2008; Cohen et al.,
2003; Krabbe et al., 2005). In natural illness models, individuals with cold, flu, or other mild
bacterial or viral infections have been found to have increased circulating IL-1β levels, but
associated cognitive impairments have not been consistently found, possibly due to a lack of
adequate experimental controls (Vollmer-Conna et al., 2004).
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In an attempt to better assess these effects, researchers have looked at the cognitive
functions of individuals exposed to a peripheral infection through injection of LPS or other
agents that are known to induce the cytokine immune response, including increasing circulating
levels of IL-1β. In one such study, Grigoleit et al. (2010) were able to produce a low-grade
inflammatory response, with an associated mild fever, but they failed to find cognitive
impairments on a wide range of declarative and non-declarative memory tests (assessed with the
Wechsler Memory Scale – Revised) or a measure of complex executive functions (Stroop ColorWord Test). Others have also failed to find impairments in attention or executive function, but
did find decreased verbal and non-verbal memory performance (Cohen et al., 2003).
Making the picture even more complex, others found decreases in declarative memory
performance but improvements in working memory performance (Reichenberg et al., 2001). In
fact, the most consistent findings across studies are decreases in processing speed and changes in
mood, including increased anxiety and depression, that likely affect other cognitive functions,
producing secondary memory and executive impairments (Grigoleit et al., 2010; Reichenberg et
al., 2001; Cohen et al., 2003). In addition, these effects are very subtle, making them difficult to
study, and are probably dependent on the type of task and the severity of the immune response.
Thus, one study that induced a very low-level of IL-1β increase failed to find any changes in
cognitive performance in the induced patients when compared to placebo control patients
(Krabbe et al., 2005).
In an attempt to study the effects of a more natural stress-induced neuroimmunological
response in healthy young adults, Shapira-Lechter et al. (2008) measured circulating IL-1β levels
and changes in mood and cognitive function among a group of healthy surgical patients, in which
patients were found to have increased levels of anxiety and depression the morning of their
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surgery that correlated with increases in IL-1β levels. In addition, patients with higher levels of
IL-1β and increased changes in mood were also found to have significantly reduced declarative
memory performance just prior to the surgery, and these effects were exacerbated in the postsurgical stage. Thus, naturally occurring changes in IL-1β have been associated with changes in
cognitive performance in neurologically healthy adults. However, these results are within the
context of a surgical procedure, in which a vast number of other factors, including postanesthesia effects, could have affected their performance.
One consistent finding of an association between immune activity and acute cognitive
changes is found in elderly populations. It is hypothesized that older aged populations have a
heightened baseline neuroinflammatory state, which makes aged populations more vulnerable to
acute infection and neural injury (see De la Fuente, 2008, for a review). The relationship
between age-related changes in neuroinflammation and vulnerability to infection and
degenerative processes is well established, but complex, and the exact role of IL-1 and other proinflammatory cytokines is only beginning to be understood.
There is evidence for both a decrease (immunosenescence) and increase (inflammaging)
in baseline neuroimmunological functioning in aged populations, both of which are related to
increased risk to infection and physical decline, and could potentially play a role in the agerelated changes in cognition (Ostan et al, 2008; Franceschi, 2007). Research into
immunosenescence has focused on declines in the adaptive immune system, including changes in
T-cell and B-cell populations and functions that prevent the initiation of an effective immune
response (Murasko, Weiner, & Kaye, 1987). There are also declines in the innate immune
system, including reduced phagocytotic functions of neutrophils and macrophages in elderly
populations that are important for elimination of pathogens (Butcher et al., 2001). On the other
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hand, inflammaging has up to now only been associated with changes in the innate immune
system, with increases in the numbers of natural killer (NK) cells that play an important role in
apoptosis, microglia activation, and cytokine activity, though the function of NK cells is often
defective, associated with a decreased sensitivity to cytokine activity (Mocchegiani & Malavolta,
2004). As discussed above, microglia are the resident immune cells of the central nervous
system and, as such, they play an important role in the release of cytokines when activated by
either extrinsic pathogens, or intrinsic triggers, such as stress. During normal aging there is an
increase in the number of primed microglia, cells that are more easily induced to producing a
rapid immune response and secrete higher levels of cytokines (Dilger & Johnson, 2008).
These changes in neuroimmunological response have been implicated in the age-related
susceptibility to cognitive impairments associated with infection and degenerative conditions.
For example, the elderly are prone to develop delirium, a condition in which a patient will
quickly develop changes in consciousness, cognitive impairments, and behavioral changes that
are typically transient (see Cerejeira, Firmino, Vaz-Serra, & Mukaetova-Ladinska, 2010, for a
review). Unlike younger populations, delirium is commonly found among the elderly with
infections, such as urinary tract infections, and in post-surgical states. About one third of elderly
patients who develop delirium are found to have a premorbid mild cognitive impairment and are
less likely to fully recover from the delirium. In addition, a significant proportion of elderly
patients who experience immune related delirium conditions are at risk for the subsequent
development of a neurocognitive condition and have a higher one year mortality rate. In
contrast, younger populations are less likely to develop immune reaction related delirium, but
also rarely experience long-term cognitive effects.
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Age-related changes in neuroimmunological baseline states are also thought to play a
critical role in neurodegenerative conditions, including dementia. The specific role of IL-1β is
unclear for dementia conditions, but there is evidence for a link between IL-1β activity and agerelated cognitive decline. Alzheimer’s disease (AD) patients have increased levels of IL-1β in
their blood and autopsy specimens (Griffin, Sheng, Roberts, & Mrak, 1995; Yasutake, Kuroda,
Yanagawa, Okamura, & Yoneda, 2006). In addition, AD patients have increased levels of IL-1β
levels following lipopolysaccharide (LPS) injections that trigger an immune response (De Luigi
et al., 2002). The level of their response is greater than that found in younger adult populations,
in keeping with the theory of a heightened neuroimmunological response for aged populations.
However, the behavioral effects of these IL-1β elevations are unclear, with one study showing
that increases in multiple inflammatory mediators, including IL-1β, were not significantly
correlated with changes in behavior or AD status (severity) among a group of clinically
diagnosed AD patients closely tracked over the course of their disease (Teunissen et al., 2003).
Yet, another study found individuals previously diagnosed with a Mild Cognitive Impairment
(Minor Neurocognitive Disorder) with deficits in multiple cognitive domains as well as AD
patients had higher levels of circulating IL-1β levels (Forlenza et al., 2009). In addition, AD
patients were found to have higher levels of circulating IL-1β on days they experienced increased
confusion and disorientation.
Genetic studies of AD patients and individuals diagnosed with related dementia
conditions have also provided supportive evidence for the importance of IL-1β and
neuroimmunological processes for cognitive functions. Genetic variations for genes that encode
IL-1α and IL-1β have been associated with risk for early onset forms of AD and the rate of
progression of AD (see Bertram & Tanzi, 2008, for a review).
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The effects of IL-1 on AD risk and disease progression are very complex and part of a
newly developing field of study that is only in the early stages of recognizing and understanding
the diversity of these genetic variations. Trompet et al. (2008) studied the cognitive functions of
elderly individuals with a genetic variation in the coding for IL-1β converting enzyme (ICE).
Patients with this variant express less IL-1β. The researchers found individuals in this
population outperformed their age-matched controls in tests of executive functions, but did not
differ significantly on memory tests. Another study of elderly Chinese males with a different
polymorphic genetic variation that also decreased IL-1β levels found similar preserved executive
functions, as well as improved working memory performance (Tsai et al., 2010). However,
individuals with a different genetic polymorphism for IL-1β were found to have no significant
difference in circulating IL-1 levels when compared to non-carriers, while they were found to
have worse working memory performance (Baune et al., 2008). This finding could reflect the
difficulty in monitoring real-time changes in circulating IL-1 levels, but also suggests alternate
pathways for IL-1 influence on cognitive functions.
Genetic polymorphisms associated with specific IL-1 functions are newly identified and
may be very limited in scope, especially when compared with more well-established gene
linkages, like those described for polymorphisms in the APOE gene. Older aged individuals who
carry at least one copy of the APOE epsilon-4 allele are at a greater risk of developing AD and,
interestingly, they have also been found to have higher baseline levels of IL-1β (Olgiati et al.,
2010). In addition, these same individuals are found to show the heightened
neuroimmunological response discussed above.
Taken together, genetic studies support the theory that neuroimmunological agents,
including IL-1β, play a critical role in cognitive functions, especially in aged populations with a
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heightened risk of inflammatory response and related cognitive impairments and
neurodegenerative conditions. While IL-1β may play a significant role in age-related cognitive
decline, its exact function is unclear, and it likely is one of several neurological agents that
contribute to the increased vulnerability found in aged populations. For example, sex-differences
point to a possible role of estrogen in modulating the effects of neuroinflammation on cognitive
functions, with evidence of estrogen-mediated enhancement in cell proliferation during learning
and memory and increased cell survival during stress within the hippocampus (Falconer &
Galea, 2003). These sex-related differences in hippocampal functions may even help explain the
finding that women experience changes in cognitive function with the depletion of estrogen
during menopause (Greendale et al., 2010) and post-menopausal female AD patients show a
more significant deterioration of cognitive abilities than men (Norbury et al., 2003).
While research in human populations has indicated a relationship between IL-1 and
cognitive functions, the biggest advances in this field of research have come from animal studies.
In these experiments the relationships between neuroimmunological changes and behavior have
especially been studied for learning and memory. The mapping of behavioral changes in
learning and memory performance to neuroanatomical regions in animal research has typically
split processes along a spatial vs. non-spatial dimension, with spatial learning and memory
processes showing a strong dependence on hippocampal regions and non-spatial processes
associated with non-hippocampal regions, including the cerebellum, basal ganglia, and frontal
cortex (e.g., Yirmiya, Winocur, & Goshen, 2002; Avital et al., 2003).
Testing the differences across spatial and non-spatial tasks with various manipulations of
IL-1β activity in mice and rats has generally found that IL-1β plays an important role in spatial
memory performance, with a less clear importance for non-spatial performance. The Morris
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water maze (MWM) is a classic tool used to study hippocampal-dependent spatial learning and
memory retention in rodents (see Sharma, Rakoczy, & Brown-Borg, 2010, for a review). In the
standard version of the test the animal is placed in a circular pool of opaque water in which a
small platform is hidden just below the water surface. Highly salient spatial cues are placed
around the testing environment to allow the animal to develop a mental spatial map of the room
and the relative position of the platform within the pool. Animals are first trained to find the
platform in an acquisition phase that typically lasts three to five days, in which the animal is
placed into the water at varying locations while the platform location is stationary across trials,
with multiple trials on a series of consecutive days. Learning performance is measured as a
function changes in the latency to find the platform and distance traveled to find the platform
over the duration of the acquisition phase. Additional measures, such as swim speed, allow for
the measurement of locomotor abilities that can be covaried out in analyses to better ascertain
true learning performance. After animals reach a pre-determined performance level that
indicates learning has occurred, they are typically tested with a memory retention probe trial. In
the probe trial, the platform is removed from the pool and memory retention is measured by the
proportion of time the animals spend in the quadrant where the platform was previously found
(goal quadrant). Animals with intact hippocampi will spend more time in the goal quadrant,
indicating a memory for the platform location. This type of learning, in which the platform
location remains constant across trials, is spatial because the animal uses constant spatial cues to
find the platform. If these cues are removed, the animal fails to learn the location of the
platform.
Animals without normal IL-1 activity have been consistently found to have poor learning
and/or memory for the platform location in standard MWM tests. In a pivotal study of the
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relationship between hippocampal-dependent memory and IL-1, Avital et al. (2003) tested male
IL1-R1 KO mice in the MWM, and found these animals had impaired learning during the
acquisition phase, with impaired latency to find the platform. The animals were generally slower
than wild-type animals, but this could not account for the learning effects. In addition, Avital et
al. found these animals had impaired memory retention, with fewer crossings in the goal
quadrant. Electrophysiological measures, discussed more fully later in this paper, showed that
animals lacking normal IL-1β activity had impaired hippocampal functioning that appeared to
lead to poor spatial learning and memory performance. It should also be noted Murray et al.
(2013) found no impairments in MWM learning and retention performance, but only tested
female IL1-R1 KO animals. In addition, both Murray and Avital used an abbreviated
acquisition-testing format of three trials per day over three consecutive days, potentially
impacting the ability to find subtler, gradual differences in learning.
Increased levels of IL-1 have also been implicated in impaired spatial learning and
memory. Oitzl, van Oers, Schöbitz, & Ron de Kloet (1993) found that the administration of
intracerebroventricular injections of IL-1 had impaired performance in the early acquisition trials
of the MWM, though these effects were time-limited. Specifically, the effects were only
significant when the injections were given one hour prior to the trial, with no significant effect
when administered immediately prior to water maze exposure. In addition, the animals were
found to have normal acquisition by the end of the acquisition training phase, indicating the
effect on spatial memory learning only modulates, but does not prevent, spatial learning.
Unfortunately, the researchers did not include a probe trial to test memory retention. More
recently, Moore et al. (2009) also found that excessive levels of IL-1β can modulate MWM
acquisition, as well as memory retention. Mutant mice bred to overexpress IL-1β when injected
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with the FIV-Cre virus were found to have impaired learning on the second day of acquisition
(though a non-significant trend), with normal learning performance by the last day of acquisition
training, but with impaired memory retention in the probe trial. Thus, IL-1, and more
specifically IL-1β, contributes strongly to long-term spatial memory performance. However, the
effect on memory retention could be secondary to impaired or altered learning processes, as
evidenced by the findings of modulated learning performance.
In an attempt to more closely study the effect of increased levels of IL-1β on the
acquisition, consolidation, and retention of spatial learning, Thomson and Sutherland (2006)
gave rats injections of IL-1β at different stages of the MWM, as well as in a delayed-matching-to
place (DMP) version of that MWM that tests working memory. In their version of the DMP
procedure, the location of the platform was changed every day or after two days, assessing the
ability for animals to generate a spatial map that is flexible and allows for consolidation of new
information to old information. They also varied the timing of IL-1β injections, including
injections prior to and immediately following acquisition trials. Thompson and Sutherland found
no impairments in MWM performance for both the working memory and standard acquisition
formats of the MWM, as well as no impairment in memory retention. They contend that IL-1β
levels were clinically significant, as the animals were found to have significant weight loss,
consistent with an overall sickness response. However, no other tests of sickness behavior were
given and animals were not found to have overall decreased swim speed, which is typically
found in the MWM when other measures of sickness behavior are significant. In addition, the
retention test was administered after animals had been through both the DMP and standard
MWM acquisition trials, making it likely that animals had overlearned the location of the task by
the time the probe trial was given. In support of their findings, Murray et al. (2013) found no
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differences in a non-spatial beacon water maze learning and memory task using female IL1-R1
KO and WT animals.
Chen et al. (2008) also tested working memory performance in mice with increased IL-1β
activity, using a version of the DMP in which the pool was adapted to accommodate a five-arm
radial maze. A hidden platform was placed at the end of different maze arms across days, thus
maintaining the requirement of acquiring a spatial cognitive map to locate the platform, but less
reliant on the need for a detailed spatial map. LPS injections were administered on the last day
of testing and performance was compared to learning on the prior day. Animals were found to
have decreased working memory performance following LPS injections, which was significantly
more pronounced for aged than young animals. In addition, the older animals were found to have
a stronger inflammatory response in the hippocampus, with a greater number of activated
microglia and higher levels of localized IL-1β, consistent with earlier discussed findings of a
heightened immune response in aging that was linked to hippocampal function and memory
performance.
While the MWM is a good measure of hippocampal-dependent spatial memory
performance, it is also sensitive to impairments in locomotor performance that can affect
interpretation of learning and memory performance. Contextual Fear Conditioning (CFC) is a
different measure of spatial memory in animals that is also impacted by locomotor functions, but
to a lesser degree than the MWM. In the standard CFC test, animals are introduced to a novel
cage and given a mild foot shock. Fear conditioning is measured by presence of a fear response
(freezing) when reintroduced to the same apparatus one to two days later. The test is a measure
of spatial memory, as the animal is conditioned to particular spatial cues to recognize the
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previously novel apparatus, but is not nearly as reliant on the ability to form a spatial map as the
MWM.
IL-1 is known to affect locomotion as part of a complex sickness behavior response
(reviewed above), which can make interpretations of MWM more difficult. Thus, the CFC
paradigm, which is less sensitive to locomotor impairments, can be used to support the findings
that impaired MWM spatial memory performance; ensuring impairments in performance are due
to impaired memory processes and not sickness-related locomotor changes. Pugh et al. (1998)
found that LPS injections, which induce a complex sickness behavior response along with the
up-regulation of IL-1β, produced impairment in CFC that was reversed with the administration
of IL1-R1a, implying the cognitive effects of the sickness response were dependent on IL-1β
activity. However, Thompson and Sutherland (2005) found IL-1β injections were not sufficient
to elicit impairments in CFC on their own. While the researchers did not measure other sickness
behaviors, they used dosage levels that typically produce sickness behavior, implying the
sickness response and related memory impairment found with LPS injections may differ from
the sickness response induced by isolated IL-1β injections. On the other hand, studies with IL1R1 KO mice have shown impaired spatial memory performance in the CFC paradigm (Avital et
al., 2003), suggesting the loss of normal IL-1β activity can affect contextual learning that is
reliant on the use of spatial information. However, Murray et al. (2013) found no difference
between IL1-R1 KO and WT animals in a tail-shock version of the CFC. Murray suggests their
contradictory findings likely reflect a difference in testing paradigms, but it should also be noted
they also conducted separate experiments and separate data analyses for the male and female
animals, which were then compared to Avital’s original study with only male animals.
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Generally, findings show spatial learning and memory performance is affected by
abnormalities in IL-1β activity, with impairments associated with both abnormally low and high
levels of IL-1β. However, the effects are inconsistent, with some studies showing effects on
acquisition and others showing effects only for retention, and performance varying across
different testing paradigms. The variability of the research has revealed an important aspect of
IL-1β effects on cognitive functions, with clear evidence of dose-dependent effects. Gibertini
(1998) trained animals in a standard MWM acquisition test, as well as a working memory
version, with injections of IL-1β administered prior to learning. Low dose injections did not
affect standard MWM learning and retention, while high dose injections actually facilitated
performance. On the other hand, low dose injections led to poor working memory performance.
However, when another group of researchers compared rats injected with either IL-1β or IL-1ra
(IL1-R1 antagonist) following the acquisition phase of the standard spatial version of the MWM,
spatial memory retention performance was impaired in a probe trial for the group with decreased
IL-1β activity and intact for animals injected with IL-1β (Yirmiya et al., 2002). While these
findings were inconsistent with the previous findings from Gibertini, the authors carefully
compared the dosage levels across the different studies and determined there was a U-shaped
dose-dependent effect of IL-1β on spatial memory performance, with an optimal moderate level
required for normal hippocampal mediated memory functions. They also proposed that absolute
levels of such dose-dependent effects likely vary across different types of behavioral tests, and
account for many of the contradictory findings in the literature.
On the other hand, testing of non-spatial memory performance more clearly shows a lack
of effect of IL-1β activity, even across different testing paradigms. There are several variations
of the MWM that reduce an animal’s reliance on spatial memory to find a platform. Typically,
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these non-spatial variants of the MWM require animals to swim to a platform that is either
visible above the water line or is marked by a salient visual cue, such as a post or flag attached to
the platform. Avital et al. (2003) found no difference in the acquisition or retention performance
of young adult male IL-1R1 KO mice and wild type animals, suggesting that a lack of IL-1β
activity has no significant impairment on non-spatial memory performance. Similarly, findings
have failed to reveal impairments in non-spatial memory performance induced by increases in
IL-1β activity. In a study of transgenic male and female young adult mice bred to overexpress
IL-1β when injected with FIV-Cre virus, acquisition rates were equivalent for IL-1β
overexpressing animals and control animals (Moore et al., 2009). These findings extended to
non-water maze paradigms, including a non-spatial fear-conditioning task. The procedure is
similar to the CFC task, except that conditioning is no longer based on association to a particular
environmental spatial context, but to an auditory cue in a novel apparatus.
While research has clearly established both IL-1’s importance in normal spatial memory
functions and its lack of significant role in non-spatial memory performance, other tests that are
not heavily spatial in format have established that IL-1 plays an important role in more general
learning and memory processes. Transgenic mice deficient in the P2X7 receptor, which mediates
the induction of IL-1β expression in the hippocampus, were found to have impaired learning in a
Y-maze task (Labrousse et al., 2009), with decreased exploration of a previously blocked maze
arm. While this task is still a spatially driven learning test, it is less reliant on having a detailed
spatial map, such as required in the MWM where the animals must use cues to find a very
specific location in a large spatial field. Rather, the delayed Y-maze test requires just the ability
to use enough spatial cues to recognize the different arms. However, impairments in
performance may also reflect a decreased interest in exploring the novel arm, which has been
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found to be affected by IL-1β levels in mice (Spadaro & Dunn, 1990). P2X7 receptor null mouse
have, however, been found to have a normal novelty-suppressed food response (Basso et al.,
2009).
IL-1β has also been found to play a role in simple motor learning in young male rats.
Larson, Hartle, and Ivanco (2007) found animals injected intraperitoneally with moderately high
doses of IL-1β were impaired in the learning of a motor task in which they were required to learn
a field of obstacles along a narrow elevated platform to reach a food reward. The effects were
not due to a reduced motivation for the reward, as animals were comparable to controls in the
speed to reach the goal on an un-obscured elevated platform.
The Hippocampus and Interleukin-1
As outlined above, IL-1 contributes to the immune response to pathogens, and also
contributes to the regulation of the HPA axis in response to threat. This effect has a wellestablished impact on sickness behavior, as well mood and cognition, and can be linked to the
role of IL-1 in the regulation of structural and functional properties of the hippocampus. The
hippocampus maintains diffuse connections with limbic and cortical structures, with more dorsal
regions associated with learning and memory functions and ventral regions associated with the
regulation of affect (see Small, Schobel, Buxton, Witter, & Barnes, 2011, for a review). Two
important aspects of the hippocampus, long-term potentiation (LTP) processes and neurogenesis,
have been linked to IL-1 and its impact on cognition and emotion.
Learning and memory are dependent on synaptic plasticity within the hippocampus, with
repeated activity at a synapse producing an enduring potentiation, reflecting a so-called
strengthening of the connection between the two cells (LTP). This synaptic plasticity is critical
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for memory consolidation, as there is often impaired learning and memory performance in
animals with blocked LTP processes (see Lynch, 2004, for a review).
As discussed above, learning and memory performance in rodents is affected by IL-1
activity, with the complete loss of IL-1 activity (Avital et al., 2003) as well as very high levels of
IL-1 (Oitzl et al., 1993) producing impairment in MWM acquisition and recall performance.
This effect may be partly explained by a disruption in hippocampal LTP processes with changing
levels of IL-1. Oitzl et al. (1993) found that the timing of IL-1 injections that was able to disrupt
learning was consistent with the time frame needed for suppression of LTP. Specifically,
injections 10 minutes prior to learning had no effect on performance, while injection 60 minutes
prior to learning had a significant impact. These findings were consistent with prior research that
has found a 25-minute window for the disruption of the mossy fiber CA3 pathway in mice
hippocampal neurons incubated with IL-1β and rat CA1 pyramidal cells that were found to have
enhanced synaptic inhibition one hour after IL-1β perfusion.
The impact of IL-1 on synaptic plasticity is not limited to LTP processes, as it has also
been found to affect short-term plasticity. Avital et al. (2003) found that IL-1R1 KO mice were
selectively impaired in spatial but not non-spatial learning and memory tests and also had deficits
in short-term plasticity, with enhanced paired pulse inhibition and decreased paired-pulse
facilitation in cells of the dentate gyrus of the hippocampus. The cells of area CA1 of the
hippocampus in these animals also showed a lack of LTP function.
The exact process by which IL-1 impairs LTP activity in the hippocampus is not yet fully
understood and is beyond the scope of the current paper. Generally, IL-1 is found to be
necessary for LTP, but at high doses inhibits LTP and acts by regulating glutamate release,
NMDA receptor function, and Ca2+ channel activity (Ross et al., 2003).
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Given that IL-1 has a negative impact on synaptic plastic and LTP, there has been a great
deal of interest in determining the relationship between neuroinflammation and impaired
memory and emotion processes associated with the hippocampus. Microglia may play an
important role in this relationship, as microglia upregulate the production of IL-1β. Transgenic
mice bred to overexpress IL-1β are found to have higher levels of activated microglia in the
hippocampus (Moore et al., 2009), and the increased activation of microglia in these animals had
a negative impact on MWM performance, with microglia activation levels that correlated with
performance impairment. In addition, mutant mice with the Swiss APP gene (Tg-SwDI) are
found to have high levels of activated microglia along with increased numbers of beta amyloid
deposits associated with Alzheimer’s disease and related impaired learning and memory
performance (Fan et al., 2007). Animals administered a long-term treatment of minocycline,
killing off the activated microglia, were found to have normal spatial memory performance on
the Barnes Maze, where they learn an escape route from an apparatus based on spatial cues.
Importantly, these changes in performance were only related to the loss of microglia activation,
but in the absence of changes in the amount of beta-amyloid deposits developed.
Synaptic plasticity, such as LTP, in the hippocampus is accompanied by another
important neural plasticity, neurogenesis. The hippocampus is one of two structures know to
undergo continuing neurogenesis throughout the lifetime, the other being the olfactory bulb. It
has been demonstrated that LTP promotes the survival and proliferation of new neurons (BruelJungerman, Davis, Rampon, & Laroche, 2006). In return, neurogenesis is thought to facilitate
synaptic plasticity in the hippocampus, as evidenced by findings that animals treated with the
DNA-methylating agent methylazoxymethanol acetate (MAM), which prevents neurogenesis,
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have disrupted hippocampal-dependent conditioned learning but not non-hippocampal-dependent
learning (Shors et al., 2001).
Recently, hippocampal neurogenesis has become a popular topic for researchers
interested in the pathophysiology and treatment of depression and anxiety; inspired by findings
that hippocampal neurogenesis is required for the behavioral effects of anti-depressant
medications (e.g., Santarelli et al., 2003). One class of antidepressants, selective serotonin
reuptake inhibitors (SSRIs), upregulate the expression of brain-derived neurotropic factor
(BDNF) within the hippocampus and promote neurogenesis (Mahlberg, Eisch, Nestler, &
Duman, 2000; Brunoni, Lopes, & Fregni, 2008). Inflammatory activity is generally known to
inhibit hippocampal neurogenesis (see Dowlati et al., 2010, for a review), yet evidence for the
relationship between neurogenesis and antidepressant efficacy has been mixed. For example,
Eyre and Baune (2012) conducted a meta-analysis of 16 studies of depressive-type behavior in
rodents exposed to a chronic stressor prior to the administration of an antidepressant. Only 11 of
the 16 studies found the antidepressant efficacy was correlated to hippocampal neurogenesis.
However, the lack of a consistent finding may also reflect differences in the timing of exposure
to the antidepressants. In fact, a later study found disruption to hippocampal neurogenesis
following the administration of an pro-inflammatory agent (LPS) was time-dependent, with
effects limited to the early stages of synaptogenesis instead of earlier stages of cell proliferation
and neuronal determination (Chugh, Nilsson, Afjei, Bokachi, & Ekdahl, 2013).
It has been shown that stress-related increases in immune activity can also have a
negative impact on hippocampal neurogenesis, and help to explain the relationship between
chronic stress and the development of mood disorders. IL-1 contributes to the regulation of HPA
axis activity, especially in conditions of chronic stress, and therefore has an impact on symptoms
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of depression and anxiety. Koo and Duman (2008) found both acute stress exposure and
administration of IL-1β are associated with suppressed hippocampal cell proliferation in rats. In
addition, these researchers found that blocking IL-1 activity (using injections of IL-1Ra in rats
and testing IL-1R1 KO mice) reduced the antineurogenic effects of both acute and chronic stress
events as well as decreased anhedonia in a sucrose preference test. These findings support
Goshen et al. (2008) who found IL-1R1 KO mice and transgenic mice bred to overexpress IL-1ra
are also spared hippocampal antineurogenesis effects associated with CUS exposure,
accompanied by a lack of a typical anhedonia response associated with this chronic stress event.
Taken together, these findings show that IL-1 upregulation, whether the result of stress or an
immune response to a pathogen, has a negative impact on hippocampal neurogenesis, in turn
contributing to depressive conditions.
The effects of stress and neuroinflammation on hippocampal function and related
behaviors are modulated by both age and sex. Aging is associated with a heightened
neuroimmunological response in humans, as discussed above, and similar findings are found in
animal models of aging and stress. Rats exposed to a stressful event (an open field test or FST)
are found to have increases in IL-1β reactive cells of the hippocampus, but this effect is much
stronger for older (1-year-old) adult mice than younger (1-month-old) juvenile mice (BadowskaSzalewska et al., 2009). These differences in the neuroimmune response carry over into
differences in LTP suppression in the presence of IL-1β injections, where aged rats (22-monthsold) were found to have a very high concentration of IL-1β concentration in the dentate gyrus of
the hippocampus when compared to younger adult animals (4-months-old), accompanied by a
higher degree of inhibition of LTP induction as well as LTP maintenance (Murray & Lynch,
1998). Older animals were also found to have a higher level of circulating corticosteroids,
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supporting the relationship between impaired LTP function and an increased
neuroimmunological states in aging.
In addition to differences in LTP suppression associated with the neuroimmunological
response, aged mice are found to have increased numbers of activated microglia and astrocytes
in the dentate gyrus of the hippocampus, as well as higher rates of impaired neurogenesis in this
area (Kuzumaki et al., 2010). It has been shown the decline in hippocampal neurogenesis
associated with aging has effects on learning and memory performance, and this relationship
seems to graded, such that animals with the largest loss of neurogenesis have the poorest
performance on the MWM test of spatial learning (Drapeau et al., 2003).
The reduction in neurogenesis in aging is not uniform, with different regions showing
higher levels of anti-neurogenesis. The hippocampus maintains a functional topographical
organization, with more dorsal (septal) regions having strong projections to the mammillary
bodies and retrosplenial cortex and more ventral (temporal) regions have strong projections to
the nucleus accumbens and reciprocal connections to the amygdala (Moser & Moser, 1998). The
dorsal regions of the hippocampus are associated with learning and memory functions, while the
ventral regions are found to have a more significant role in emotion and anxiety-related behavior
(Fanselow & Dong, 2010). Jinno and Kosaka (2010) compared young (2-months-old) and older
(10-months-old) adult mice for neurogenesis in these different regions. There was an overall
finding of greater neurogenesis in dorsal regions than ventral regions, for both young and old
animals, but the older animals had an overall lower rate of neurogenesis, and this was especially
reduced in the ventral regions. Importantly, there were no changes in gliogenesis across the age
groups. These findings are consistent with findings in aged human populations that depression
frequently precedes dementia in aged populations (Korczyn & Halperin, 2009).
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In addition to age-differences in immunological responses to stress, sex modifies the
effects of stress on hippocampal neurogenesis. Circulating levels of ovarian hormones (estradiol,
progesterone, and corticosterone) in the estrous cycle affect neurogenesis, and appear to have a
protective effect on neurogenesis in times of stress. Male animals display suppression of
neurogenesis when exposed to a predator odor (Falconer & Galea, 2003) or acute foot shock
(Shors et al., 2007) accompanied by increases in corticosterone, while females will still have an
increase in corticosterone levels, but no suppression in neurogenesis. A similar finding of
preserved neurogenesis for females has also been found with chronic stress exposure
(Westenbroek, Den Boer, Veenhuis, & Ter Horst, 2004). These findings are attributed to a sexbased difference in HPA axis functioning, where females have higher baseline levels of
corticosterone and a reduced spiking of these levels in response to more moderate chronic stress
events (Brummelte & Galea, 2010). Female rodents undergo estrous and acyclicity as they age,
leading to a reduction in cycling ovarian hormones. The loss of ovarian hormones has been
found to increase basal neuroinflammation due to a reduction in anti-inflammatory estrogen
receptors in aged ovariectomized mice (Bendusi et al., 2012). Generally, research shows chronic
and moderate levels of circulating ovarian hormones are associated with an increase in
hippocampal neurogenesis (see Pawluski, Brummelte, Barha, Crozier, & Galea, 2009, for a
review). However, most of this research is conducted with ovariectomized animals and estradiol
injections and the findings are inconsistent across studies. In fact, it has been well documented
these sex-based differences even vary across species, with voles, rats, and mice having been the
primary research subjects (see Gould & Tanapat, 1999, for a review). Lagace, Fischer, and Eisch
(2007) extended these findings to find a species-specific age by sex interaction effect, in which
the administration of the anti-depressant fluoxetine preserved neurogenesis in aged female rats,
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but not aged male rats, nor female nor aged mice. Despite the variability in research findings,
there is overall support for sex-based differences in neurogenesis, which can help to explain sexbased differences in depression and memory, especially with aging in human populations. Thus,
with the loss of circulating ovarian hormones there is loss of neuroplasticity in the hippocampus,
which can differentially impair females and males, especially for aged populations.
The Current Study
Recent investigations with human clinical populations, as well as animal models have
demonstrated the important of IL-1 for complex emotional and cognitive functions, including
depression, anxiety, learning and memory. These effects, especially for depressive symptoms,
are found to differ across the sexes, especially for aged populations, coinciding with changes in
the neuroimmune system. In addition, aged populations are prone to cognitive decline, which
has also been linked to neuroinflammatory changes.
IL1-R1 KO mice have been important in studying the role of IL-1 in young adult animals
for emotional and cognitive functions, but there has yet to be a comprehensive study of the
effects of age and sex with these animals (see Appendix B for a summary of prior behavioral
studies of IL1-R1 KO animals). The current study looks at the role of IL-1 activity on a general
spectrum by conducting a series of behavioral and neuroanatomical measures of an IL1-R1 KO
mouse, including both male and female animals. First, a broad-based behavioral phenotyping
battery was conducted, measuring general activity, locomotion, facial morphometrics, emotional
responses, and cognitive functions. Second, to determine age-related changes in these behavioral
tests, a subset of behaviors were tested at two different ages, in younger adult animals (2–5
months of age) and in older adult animals (12–14 months of age). Third, possible
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neuroanatomical parameters were explored, including differences in gross anatomy, structural
abnormalities, and the general morphology and distribution of microglial cell populations.
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CHAPTER 2: GENERAL METHODS
Subjects
Adult IL1-R1 KO mice and WT mice (on a C57B1/6 background strain, obtained from or
bred from Jackson Laboratory stock) were used. A total of 24 IL1-R1 knockout mice (12 male,
12 female) and 24 wild-type mice (12 male, 12 female) were tested, balanced for sex and tested
in two cohorts. One animal (KO female) died after completing only the FST. Animals were
housed three to six per cage and provided food and water ad libitum. The housing facility was
maintained at 23° C with lights on from 7:00 AM to 7:00 PM. All procedures were approved by
and met strict compliance requirements of the Institutional Animal Care and Use Committee of
the Queens College of the City University of New York. Animals were approximately two to 13
months of age during behavioral testing (see Appendix B for cohort ages for each behavioral
test). A subgroup of behavioral tests was administered twice to evaluate age effects, with a range
of approximately six to 11 months between testing sessions. Animals were approximately 14
months of age at time of sacrifice for neuroanatomical measures.
Rarely, individual animals were excluded from specific behavioral tests due to physical
limitations (skin lesions and/or poor motor control). Animals were acclimated to testing rooms
in their home cages for 60 minutes prior to behavioral testing, and the same experimenters were
used across days for each behavioral test. Behavioral testing materials were cleaned and wiped
down before and after each animal was tested, unless otherwise specified. At least one
experimenter was blind to animal genotype during testing, and a blinded evaluator scored all
behavioral data. Experimental groups were tested in random sequences across different
behavioral tests and testing days.
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Statistical Analyses
Statistical analyses were conducted using the Statistical Package for the Social Sciences
(SPSS) software version 22 (IBM Corp. Armonk, NY). All tests were conducted with both male
and female animals, and analyses focused on gender and sex effects, as well as genotype by sex
interaction. Age effects were also analyzed for a subset of tests administered at two different
ages. Some tests were conducted on a single cohort of animals, while other behavioral tests were
conducted using both animal cohorts. In tests where both cohorts were tested, cohort effects
were evaluated. In most instances, no significant cohort effect was observed, nor were there
significant interactions between the cohort variable and other variables of interest and the
reported data is based on combined cohorts. Analyses with a significant cohort interaction
effects were further assessed with adjustments to the data to balance out cohort differences, and
in most instances revealed no change in the significance of other variables of interest. Again, in
these instances the reported data is based on combined cohorts, unless otherwise indicated. In
addition, in the rare case adjustments for cohort effects revealed a significant effect that had
previously been masked by cohort interaction effect; the resulting analyses are reported for the
adjusted data values, with the adjustments explained more fully for that particular measure.
Extreme individual data points of two or more standard deviations from a specific
measure mean were removed from reported data sets. The removal of outliers is accounted for in
the results for each individual measure.
Figures
Data in figures are presented as means and standard error of the means. Asterisks (*)
represent results that are statistically significant at p < .05.
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CHAPTER 3: SPECIFIC AIM 1
Specific Aim 1 was to study the behavior and gross phenotype of IL1-R1 knock out (KO)
mice using a broad-based behavioral and gross anatomical phenotyping battery that
included measures of general activity and locomotion, facial morphometrics, emotional
responses, and cognitive functions.
IL1-R1 KO mice have reduced signaling of the IL-1 pathway, making them a convenient
model for testing the importance of IL-1 in normal behavioral activity (Glaccum et al., 1997).
As reviewed earlier, IL-1 plays an important role in the neuroinflammatory response and
sickness behavior, as well as normal hippocampal functioning that impacts both cognitive and
emotional processes (Blanco et al., 2008). However, prior research conducted with IL1-R1 KO
animals has been limited to primarily male animals and also limited to a subset of cognitive and
emotional behavior (e.g., Koo & Duman, 2008). In the one case of a study that included both
male and female animals in four behavioral tests (elevated plus, Y-maze, CFC, and open field),
but each sex was tested in separately with separate data analyses (Murray et al., 2013).
Therefore, the current study seeks to expand testing to include both male and female animals
across a broader array of behaviors, tested in the same cohorts. Animals were tested for their
general activity and locomotor functions, as abnormalities could indicate a sickness-type
response (Bison et al, 2009). Morphometric measures of facial features were also quantified, as
IL-1 activity has been shown to be necessary for normal embryonic and neuro-developmental
processes, including guiding cortical cell migration (Ma et al., 2014) and postnatal bone growth
in rats (MacRae, Ahmed, Mushtaq, & Farquharson, 2007). Emotional and cognitive functions
were tested, including tests applied in prior research with IL1-R1 KO mice (e.g., MWM and
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Elevated Plus Maze, both tested by Koo and Duman, 2009) and measures previously untested
with this KO mouse strain (e.g., Social Interaction Test and the FST).
Specific Methods
General Activity and Locomotion
Gait.
Animals. A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. An enclosed straight runway measuring 94 x 7 x 10 cm was lined with white
paper. Non-toxic red paint was applied with a paintbrush to the fore paws while non-toxic blue
paint was applied to the hind paws. Animals were placed at the start of the runway and gently
prodded to run the length of the runway. Repeated trials were required for some animals until a
series of at least three complete paw placement sequences could be visualized. Measurements
were obtained for stride length (distance from one placement of the paw to the next placement of
the paw) for all four paws, stride width (distance between right and left paws) for both fore and
hind paws, and interstep distance (measurement of the length between consecutive steps) for
both fore and hind paws. Three samples were obtained for each measurement, with the median
of the three used for subsequent analyses.
Facial Morphometrics
Snout Morphometrics.
Animals. A total of 12 IL1-R1 KO mice (6 male, 6 female) and 12 WT mice (6 male, 6
female) were tested.
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Procedure. Using a digital camera, animal faces were photographed against a ruler with
their eyes open and whiskers spread. Pictures were then viewed on a computer and
measurements were calibrated with the ruler. Measurements were calculated for philtrum length
(distance from the center top edge of the mouth to the top of the base of the nose), and snout
length (distance from the midline of the eyes down to the tip of the snout).
Eye Morphometrics.
Animals. A total of 12 IL1-R1 KO mice (6 male, 6 female) and 12 WT mice (6 male, 6
female) were tested.
Procedure. Using a digital camera, animal faces were photographed against a ruler with
their eyes open and whiskers spread. Pictures were then viewed on a computer and
measurements were calibrated with the ruler. Measurements were calculated for the inner
canthal length (distance between the proximal corners of the right and left eyes), outer canthal
length (distance between the distal corners of the right and left eyes), palpebral fissure width
(peak distance between the lower and upper eyelid edges), and palpebral fissure length (peak
distance between the proximal and distal corners of the eye).
Visual Cliff.
Animals. A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. Following up on early observations that some animals appeared to have
smaller eyes, animals were tested on the visual cliff to test for visual impairment. A clear
Plexiglas sheet measuring 45 x 20 cm was placed on a rectangular frame that visually divided the
field into two distinct areas. The “cliff” area was open to give the appearance of a drop in height
of 20 cm. The “safe” area was darkened, giving the appearance of solid ground. Animals were
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placed in the middle of the safe side of the apparatus and allowed to freely explore the safe and
cliff sides for three minutes. Number of entries and total time spent on the cliff and safe sides
was recorded. Normal animals are expected to approach the cliff side with caution, while
uninhibited exploration of the cliff side could indicate an inability to perceive the apparent cliff
and possible visual impairment.
Emotional Responses
Open Field.
Animals. A total of 22 IL1-R1 KO mice (12 male, 10 female) and 22 WT mice (10 male,
12 female) were tested in two cohorts. Three additional animals (two WT males and one KO
female) were not tested due to the presence of sores and diminished body weight suggestive of
poor health.
Procedure. Animals were placed in a white, box-shaped apparatus measuring 50 x 50
cm, divided by tape into a 3 x 3 grid. Each grid square measured 16.67 x 16.67 cm, with eight
“outer” squares bordering an outer wall and one open “inner” square. Animals were placed in
the inner square and allowed to freely explore for six minutes. Exploration was assessed by
counting the number of crossings made across grid lines during three continuous two-minute
periods (“bins”), reflecting general locomotor and exploratory behavior. Animals’ latencies to
exit the center square and initiate grooming activities were scored. The number of grooming and
rearing behaviors were also counted. These measures are thought to assess anxiety-like
behavior, as animals have a natural tendency to avoid open areas where they are at greater risk
for predators. It is expected that normal animals will, over time, increase their exploration of the
center of the apparatus, while more anxious animals will instead hug the walls of the apparatus.
Normally, when first placed in the apparatus, animals will quickly exit the center square to seek
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the safety of an outer wall, but an anxious animal may show a fear-related freezing response,
resulting in increased latencies to exit the center square. In addition, the latency and frequency
of grooming and rearing behaviors are thought to be indicators of both of both heightened and
reduced anxiety levels (Kalueff & Tuohimaa, 2005). For example, increased anxiety may lead to
compulsive-type behaviors, with a decreased latency to groom and overall increase in the
frequency of grooming behaviors. However, both low and high levels of stress have also been
associated with increased grooming behavior, as measured in the total time spent grooming.
Elevated Plus Maze.
Animals. A total of 23 IL1-R1 KO mice (12 male, 11 female) and 23 WT mice (11 male,
12 female) were tested in two cohorts. One additional animal (one WT male) was not tested due
to the presence of sores and diminished body weight suggestive of poor health.
Procedure. The elevated plus maze apparatus was comprised of a central platform,
measuring 15 x 15 cm and elevated 114 cm above the floor. Arms were attached to each of the
sides of the central platform (measuring 61 x 15 cm) in a “plus” shape, at the same height as the
central platform. Two opposite arms were painted white and had no walls (“open” arms) while
the other two arms were painted black and enclosed with 30 cm high walls (“closed” arms).
Animals were placed on the center platform and allowed to freely explore for five minutes.
Latency to exit the platform was recorded. Longer latencies to exit the center platform when
placed on the apparatus are indicative of a strong anxiety-type response, as the animal freezes in
place before seeking safety in one of the closed arms. Additionally, and the proportion of time
spent on the open arms, closed arms, and central platform were scored. Increased time spent in
the closed arms is thought to indicate a heightened level of anxiety, as animals will avoid
exposure to predators in the open arms.
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Novelty-Suppressed Feeding.
Animals. A total of 11 IL1-R1 KO mice (5 male, 6 female) and 11 WT mice (6 male, 5
female) were tested. One additional animal (one WT male) was not tested due to the presence of
sores and diminished body weight suggestive of poor health.
Procedure. Animals were food-deprived for 24 hours and then placed into the open field
apparatus described above. After a five-minute habituation period, animals were removed and a
mash made of the animals’ standard food pellets (PicoLab Mouse Diet 20, LabDiet, St. Louis,
MO) and water was placed on a piece of waxed paper secured to the middle of the central grid
square. Each animal was immediately reintroduced to the apparatus in a corner distant from the
food. Latencies to first sniffing or biting of the food mash were measured, as well as total
number of approaches (sniffs or bites) and entries into the center grid square over a five-minute
trial. Normally, animals will explore the introduction of a desirable novel stimulus (the food
mash) in a familiar environment, even if the stimulus is placed in an open, exposed area.
Increased latency to approach the food and fewer approaches to the food or entries into the center
grid square are indicative of increased anxiety, suppressing the instinct to explore the desirable
novel stimulus.
Y-Maze.
Animals. A total of 11 IL1-R1 KO animals (6 male, 5 female) and 12 WT animals (6
male, 6 female) were tested.
Procedure. The Y-maze apparatus was comprised of an enclosed starting runway
measuring 30 x 9 x 10 cm, terminating in two identical upper arms measuring 30 x 9 x 10 cm
each, at a 45 degree angle from the starting runway. Animal home cages were placed between
the two upper arms at the top of the Y-end of the maze as a motivator for animals to move
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towards the end of the maze. A plastic opaque rectangle was placed approximately 10 cm from
the starting end of the runway before each trial. The animal was placed in the starting end of the
runway. The plastic barrier was then removed and the animal was allowed to freely explore the
maze until entering one of the upper arms. After entering an arm the animal was removed from
the apparatus. The apparatus was then cleaned and the barrier was replaced before the animal
was placed back into the starting arm for the next trial. A total of 11 trials were given, and the
choice of arm was recorded in order to calculate total number of perseverations (re-entries to
same arm) and alternations (entries into the opposite arm). No time limit was applied, but in the
rare case of animals that failed to explore one of the upper arms within five minutes, the plastic
was tapped at the starting end of the apparatus, prodding the animal to progress to the end of the
apparatus. Normally, animals are expected to alternate arm entries in order to more fully explore
the apparatus, while an increased proportion of repetitive responses is reflective of perseverativetype behaviors.
Light-Dark Exploration.
Animals. A total of 24 IL1-R1 KO mice (12 male, 12 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. Animals were placed into a rectangular box measuring 45 x 20 x 20 cm, half
of which was covered and painted black (“dark” side) and the other half of which had no cover
and was painted white (“light” side). Animals were placed into the light side and allowed to
freely explore for five minutes. Total time spent on the light and dark sides were recorded.
Latency to enter the dark side of the apparatus was also recorded. Normally, animals will tend to
spend more time on the dark side of the apparatus, as they avoid the more open, light, area where
they are at a greater risk for exposure to predators. Increased time spent in the dark side of the
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apparatus is associated with increased anxiety, and freezing behavior is associated with an
increased latency to exit the light side of the apparatus.
Porsolt Forced-Swim Test (FST).
Animals. A total of 24 IL1-R1 KO mice (12 male, 12 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. Animals were placed into a small pool (33 x 34 cm) of room-temperature
water with a water depth of 30 cm and 26.5 cm walls extending above the water’s surface, from
which they could not escape. During the training period animals were placed in the center of the
pool and allowed to explore for 15 minutes. After 24 hours, the animals were placed in the same
pool of water for the test session and left to freely explore for five minutes. Total time spent
immobile (floating with no escape-related behaviors) was recorded during the test session.
Increased time spent immobile during the second day of testing is indicative of a learnedhelplessness type response, and associated with a depressive-type condition.
Social Behavior
Social Interaction.
Animals. A total of 10 IL1-R1 KO animals (5 male, 5 female) and 10 WT animals (5
male, 5 female) were tested. Three additional animals (one WT male, one WT female, and one
KO male) were not tested due to the presence of sores and diminished body weight suggestive of
poor health.
Procedure. Animals were placed in the apparatus previously described above for the
Open Field Test. A novel WT (“stranger”) mouse was placed on the center grid square and
allowed to freely explore the field. Stranger animals were matched for sex and approximate size
to the test animal. Fifteen seconds later the test animal was placed on the center square and both
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animals were left to explore freely for five minutes. Social contact behaviors initiated by the test
animal were recorded, including total number of face-to-face and face-to-body contacts. The
latency to first face-to-face contact initiated by the test animals was also recorded. The number
of aggressive acts (biting, fighting, etc.) initiated by either animal was recorded. “Following”
behavior was recorded as the number of grid crossings made while following the stranger mouse.
Aggressive acts and following behavior are both considered inappropriate social behaviors, and
associated with impairments in social functioning.
Cognitive Functions
Morris Water Maze (MWM) Acquisition.
Animals. A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. A plastic pool painted with non-toxic white paint measuring 105cm in
diameter with a water depth of 35cm was placed in a room measuring 1.38 m x 2.13 m with high
contrast spatial cues on the walls that were kept constant throughout testing. The water was
made opaque with non-toxic white paint in order to camouflage a 14 cm round plastic platform
hidden 2.5 cm below the water surface. The pool was conceptually divided into four equal
quadrants, one of which held the hidden platform 10 cm from the pool wall (“goal” quadrant).
Animals were placed in one of the non-goal quadrants at the start of each trial, in a pseudorandom order across three trials (a “trial block”). During acquisition, animals were tested for
latency to find the platform in the goal quadrant across four to six days, with two or three trial
blocks per day until control animals achieved criterion latencies of fewer than 10 seconds to
locate the hidden platform. Individual cohorts required 9–12 blocks to reach criterion. Animals
unable to find the platform within 60 seconds were directed to the platform by the experimenter
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and assigned a latency of 60 seconds for that trial. In addition to latency measures, mean
quadrant crossing time was recorded as an estimate of swim speed. Normally, animals will show
a decreased latency to find the platform over trial blocks, indicating acquisition of the spatial
location of the platform.
Morris Water Maze (MWM) Retention.
Animals. A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male,
12 female) were tested in two cohorts.
Procedure. One hour after the final trial block of acquisition, animals were tested for
retention of goal quadrant location on a spatial probe trial. The platform was removed and
animals were placed in the center of the pool facing away from the quadrant that had previously
contained the escape platform (i.e., the goal quadrant). Animals were tested for the amount of
time they spent in each of the four quadrants over a 30-second retention trial. Normal animals
will spend proportionally more time in the goal quadrant than the adjacent or opposite quadrants,
indicating an ability to retain the spatial location of the platform.
Object Placement.
Animals. A total of 23 IL1-R1 KO animals (12 male, 11 female) and 23 WT animals (10
male, 12 female) were tested in two cohorts. One additional animal (one WT male) was not
tested due to the presence of sores and diminished body weight suggestive of poor health.
Procedure. Animals were tested in the apparatus previously described above for the
Open Field Test. During an initial habituation period, two identical objects (mugs placed on
their sides) were placed in the field and the animal was left to freely explore for five minutes.
The animal was then removed while one of the two objects was moved (“novel” object location).
During the testing phase the animal was reintroduced to the apparatus in the center square,
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equidistant from each object, and allowed to freely explore for five minutes. Total time spent
with each object was recorded to assess spatial novelty recognition. Animals have a preference
for exploring novel objects, and are expected to explore the moved object more than the
stationary object. A preference for the novel object illustrates learning and recognition
processes, and a failure to show a preference for the novel object indicates impaired memory
functions.
Statistical Analyses
Most analyses were conducted with separate univariate ANOVA tests to assess
differences between KO and WT animals for each measure for most behavioral tests. Animals
were also tested for changes in performance over time on some measures, in which case a
repeated measures factor was added to the Factorial ANOVA, making it a mixed Factorial
ANOVA, as reported in results. In addition, in some cases a MANOVA test was conducted for
related measures, also reported in results. Appropriate alpha adjustments for significant testing
were made to accommodate for multiple testing.
Results
General Activity and Locomotion
Open Field. IL1-R1 animals did not significantly differ from WT animals in the total
number of grid crossings in the open field test [F (1, 40) = 1.965, p = 0.169; see Figure 1]. In
addition, there were no significant sex differences [F (1, 40) = 0.186, p = 0.669], nor a genotype
by sex interaction [F (1, 40) = 2.184, p = 0.147]. Therefore, there appear to be no impairments
in general locomotor functions across the different groups.
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Figure 1. Open field total grid crossings for IL1-R1 KO and WT mice. n = 11–12/
group.

Gait. Outlier scores (two or more standard deviations away from the mean) were
removed for the stride length (one WT male and one WT female), stride width (one WT female
and one KO female), and interstep distance (two WT females) analyses. IL1-R1 KO animals did
not significantly differ from WT animals on any of the gait measures, including stride length for
each paw (see Table 1), stride width (see Table 2) or interstep distance (see Table 3), with no
significant sex effects, nor genotype by sex interactions (see Figure 2).
Table 1: Stride Length
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
0.358 (3, 123)
0.879 (3, 123)
0.177 (3, 123)

p
0.752
0.441
0.886

F (df)
0.213 (1, 41)
0.01 (1, 41)
0.775 (1, 41)

p
0.647
0.923
0.384

Table 2: Stride Width
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
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Table 3: Interstep Distance
F (df)
1.056(1, 41)
0.753 (1, 41)
1.388 (1, 41)

Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

A

p
0.310
0.391
0.246

9
8

Distance (mm)

7
6
Male WT

5

Male KO

4

Female WT

3

Female KO

2
1
0
Left Fore Paw Right Fore Paw Left Hind Paw Right Hind Paw

C

4

Length (mm)

Length (mm)

B

3
2
1
0

5
4
3
2
1
0

Fore Paws

Hind Paws

Fore Paws

Hind Paws

Figure 2. Gait measurements of stride length for each paw (A), stride width (B) and
interstep distance (C) for IL1-R1 KO and WT mice. n = 10–12/group.
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Facial Morphometrics
Snout Morphometrics. Outlier scores for one animal (KO female) were removed from
both snout morphometric measures. Female animals had significantly longer snouts than males
(see Table 4). However, there were no significant differences between genotypes for snout
length, nor a significant genotype by sex interaction (see Figure 3 and Table 4). There were no
significant differences for philtrum length (distance from the center top edge of the mouth to the
top of the base of the nose).
Table 4: Snout Morphometrics
Philtrum Length
Genotype
Sex
Genotype x Sex
Snout Length
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)

p

4.212 (1, 19)
4.212 (1, 19)
0.468 (1, 19)

0.054
0.054
0.502

0.032 (1, 19)
9.272 (1, 19)
0.289 (1, 19)

0.860
0.007*
0.597

*

1.6

Length (mm)

1.4
1.2
1

Male WT

0.8

Male KO

0.6

Female WT

0.4

Female KO

0.2
0
philtrum length

snout length

Figure 3. Snout shape and size, as measured with philtrum length and snout width for
IL1-R1 KO and WT mice. n = 6/group.
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Eye Morphometrics. Outlier scores for one animal (KO female) were removed from all
eye morphometric measures. Eye morphometrics were analyzed in a single MANOVA test.
IL1-R1 KO animals were found to have significantly smaller eyes than the WT animals (see
Figure 4). Specifically, IL1-R1 KO animals had a smaller average palpebral fissure length (peak
distance between the proximal and distal corners of the eye) than WT animals, with no sex or sex
by genotype interaction (see Table 5). All other eye measurements were not significant,
indicating that the placement of the eyes within the face was normal for KO animals.
Table 5: Eye Morphometrics
Inner Canthal Distance
Genotype
Sex
Genotype x Sex
Outer Canthal Distance
Genotype
Sex
Genotype x Sex
Palpebral Fissure Length
Genotype
Sex
Genotype x Sex
Palpebral Fissure Width
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)

p

0.016 (1, 19)
0.036 (1, 19)
1.17 (1, 19)

0.900
0.851
0.293

2.305 (1, 19)
0.814 (1, 19)
0.059 (1, 19)

0.145
0.378
0.811

7.307 (1, 19)
0.92 (1, 19)
0.616 (1, 19)

0.014*
0.350
0.442

0.243 (1, 19)
0.108 (1, 19)
1.729 (1, 19)

0.628
0.746
0.204

Length/Distance (mm)

64
1.4
1.2
1
0.8
0.6
0.4
0.2
0

Male WT
Male KO
Female WT
Female KO

*

*

Inner Canthal Outer Canthal
Palpebral
Palpebral
Distance
Distance
Fissure Length Fissure Width

Figure 4. Eye shape and size, as measured with inner canthal distance, outer
canthal distance, palpebral fissure length, and palpebral fissure width for IL1-R1
KO and WT mice. n = 6/group.

Visual Cliff. To evaluate whether the reduced eye size in the IL1-R1 KO mice was
associated with loss of vision, we conducted the visual cliff test as a surrogate screen for
blindness. There were no significant effects for genotype [F (1, 43) = 0.259, p = 0.613] or sex [F
(1, 43) = 0.256, p = 0.615], and no genotype by sex interaction [Genotype*Sex: F (1, 43) = .001,
p = 0.997] on the proportion of time spent on the cliff side of apparatus. Thus, despite having
smaller eyes, we could find no evidence that IL1-R1 KO animals are blind or have functional
impairments in depth perception (see Figure 5), although we cannot rule out differences in visual
acuity.
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Figure 5. Proportion of time spent on the cliff side of the visual cliff apparatus for
IL1-R1 KO and WT mice. n = 11–12/group.

Emotional Responses
Open Field. Outlier scores for two animals (one KO female and one WT male) were removed
for the latency to exit the center square analyses. There was a significant genotype by sex
interaction effect for the latency to exit the center square, but no overall significant main effect
for genotype or sex on the same measure (see Table 6). Specifically, WT male animals were
found to take longer to exit the center square, with a mean latency of 1.9 seconds (SEM = 0.35),
while all other groups had a mean latency of at least 1.3 seconds faster (see Figure 6). There
were no significant genotype, sex, or genotype by sex interaction effects for the proportion of
grid crossings into the center grid square (see Table 7). In a mixed Factorial ANOVA the
proportion of crossings across three different time intervals (bins) was also not significant for
differences by genotype or sex (see Table 8). Grooming and rearing behavior measures also
yielded no significant effects (see Tables 9–11).
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Table 6: Open Field Latency to Exit Center Square
F (df)
Genotype
2.389 (1, 38)
Sex
2.389 (1, 38)
Genotype x Sex
9.554 (1, 38)
* significant at the p < .05 level

p
0.131
0.131
0.004*

Table 7: Open Field Inner Crossings
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
0.006 (1, 40)
0.058 (1, 40)
0.011 (1, 40)

p
0.939
0.811
0.918

F (df)
0.74 (2, 80)
0.634 (2, 80)
1.861 (2, 80)

p
0.439
0.484
0.174

F (df)
0.258 (1, 40)
0.008 (1, 40)
0.038 (1, 40)

p
0.615
0.931
0.846

F (df)
0.024 (1, 40)
0.024 (1, 40)
0.865 (1, 40)

p
0.878
0.878
0.358

Table 8: Open Field Bin Crossings
Bin x Genotype
Bin x Sex
Bin x Genotype x Sex
* significant at the p < .05 level
Table 9: Open Field Latency to First Groom
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
Table 10: Open Field Total Grooms
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
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Table 11: Open Field Total Rears
F (df)
0.004 (1, 40)
0.76 (1, 40)
0.151 (1, 40)

Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

B

A
KO

WT
Proportion Inner

Latency (seconds)

WT
3
2

*

1
0
Male

KO

0.2
0.15
0.1
0.05
0

Female
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Female
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C

WT

KO

WT

200

Total Grooms
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p
0.947
0.388
0.700
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Figure 6. Open%field%latency%to%first%exit%the%center%square%(A),%proportion%of%inner%
grid%crossings%(B),%latency%to%first%groom%(C),%total%grooms"(D),"and"total"rearing"
behavior)(E))for)IL1!R1#KO#and#WT#mice.#n = 11–12/group.

68
Elevated Plus. IL1-R1KO animals did not significantly differ from WT animals on any
of the elevated plus measures, including the proportion of time spent on the closed arms, open
arms, or the central platform (see Tables 12–14). There were also no significant sex effects or
genotype by sex interactions for any of the three measures (see Figure 7).
Table 12: Proportion of Time in Open Arms
F (df)
0.946 (1, 42)
0.01 (1, 42)
2.229 (1, 42)

p
0.336
0.921
0.143

F (df)
0.464 (1, 42)
0.009 (1, 42)
2.303 (1, 42)

p
0.499
0.925
0.137

Table 14: Proportion of Time on Central Platform
F (df)
Genotype
0.149 (1, 42)
Sex
0.067 (1, 42)
Genotype x Sex
1.358 (1, 42)
* significant at the p < .05 level

p
0.701
0.797
0.250

Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
Table 13: Proportion of Time in Closed Arms
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

Proportion of Time
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Figure 7. Proportion of time spent in the open arms, closed arms, or central platform
of the elevated plus maze apparatus for IL1-R1 KO and WT mice. n = 11–12/group.

Novelty-Suppressed Feeding. There was a significant sex by genotype interaction for
both the total number of approaches made towards the food and the total number of entries into
the center grid square, with no significant main effects for either genotype or sex on either of
these measures (see Tables 15 and 16). Both of the significant interactions showed that male
IL1-R1 KO animals made more entries into the middle square, approaching the novel food
stimulus, than the WT males, while the inverse pattern was found with the female animals (see
Figure 8). These data suggest either enhanced reward-motivated exploratory drive or decreased
anxiety in the male KO mice. No significant effects were found for the two latency measures
(latency to first sniff or bite of the novel food stimulus) or the latency to first enter the center grid
square (see Tables 17 and 18).
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Table 15: Total Sniffs or Bites
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
0 (1, 18)
0.445 (1, 18)
4.45 (1, 18)

p
0.989
0.513
0.049*

F (df)
0.795 (1, 18)
0.065 (1, 18)
5.858 (1, 18)

p
0.384
0.802
0.026*

F (df)
0.159 (1, 18)
0.009 (1, 18)
0.024 (1, 18)

p
0.659
0.927
0.878

F (df)
0.866 (1, 18)
1.544 (1, 18)
0.866 (1, 18)

p
0.790
0.230
0.364

Table 16: Total Center Square Entries
Genotype
Sex
Genotype* x Sex
* significant at the p < .05 level
Table 17: Latency to First Sniff or Bite
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
Table 18: Latency to Enter Center Square
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
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Figure 8. Total sniffs or bites (A), total center square entries (B), mean latency to
sniff or bite (C), and mean latency to enter the center square in the novelty-suppressed
feeding test for IL1-R1 KO and WT mice. n = 5–6/group/
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Y-Maze. IL1-R1 KO animals were not found to differ significantly from WT animals in
the proportion of perseverative-type responses in the Y-maze [F (1, 19) = 0.350, p = 0.561].
There was also no significant effect for sex [F (1, 19) = 0.014, p = 0.907], nor a significant
genotype by sex interaction [F (1, 19) = 1.695, p = 0.209].
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Figure 9. Proportion of perseverative responses for IL1-R1 KO and WT mice in the
Y-maze. n = 5–6/group.

Light-Dark. The proportion of time spent on the light side of the apparatus did not
significantly differ by genotype [F (1,43) = 0.267, p = 0.608] or sex [F (1, 43) = 0.536, p =
0.468], and there was no significant genotype by sex interaction [F (1, 43) = 0.428, p = 0.517].

73
0.4
Proportion of Time
on Light Side

0.35
0.3
0.25
0.2

WT

0.15

KO

0.1
0.05
0
Male

Female

Figure 10. Proportion of time spent on the light side of the light-dark apparatus for
IL1-R1 KO and WT mice. n = 11–12/group.

Porsolt Forced-Swim Test (FST). There was a significant overall main effect for the
cohort variable in the FST [F (1, 40) = 8.456, p = 0.006], but no significant interactions with
cohort, suggesting that the baseline measurements of time spent immobile were different
between the two cohorts. Specifically, the first cohort, on average, spent more time immobile on
day two in the apparatus (M = 189.292, SEM = 8.825) than the second cohort (M = 153.00, SEM
= 8.825). Therefore, a cohort adjustment (correction) was made by adding 40 seconds to each
data point in the second cohort, regardless of sex or genotype, to allow cohorts to be combined
for an analysis of genotype and sex effects. These adjusted values revealed a significant
genotype by sex interaction [F (1, 44) = 4.436, p = 0.041], with no overall significant main
effects for genotype [F (1, 44) = 2.240, p = 0.142] or sex [F (1, 44) = 0.548, p = 0.463]. A
simple effects analysis further revealed KO females spent more time immobile than WT females
[F (1, 44) = 6.491, p = .014], while KO and WT males did not significantly differ from one
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another [F (1, 44) = 0.189, p = .669], suggesting female KO animals had more learned
helplessness.
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Figure 11. Time immobile in the FST for younger IL1-R1 KO and WT mice. Mean
values are adjusted for cohort effect. n = 12/group.

Social Behavior
Social Interaction. IL1-R1 KO animals were not found to significantly differ from WT
animals across all social contact behaviors (latency to first face-to-face contact, total face-to-face
contacts, and total face-to-body contacts) or atypical behaviors (total aggressive acts and
following), see Tables 19–23.
Table 19: Latency to First Face-to-Face Contact
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
0.332 (1, 16)
1.521 (1, 16)
0 (1, 16)

p
0.573
0.235
0.997
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Table 20: Total Face-to-Face Contacts
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
1.69 (1, 16)
1.69 (1, 16)
1.69 (1, 16)

p
0.212
0.212
0.212

Table 21: Total Face-to-Body Contacts
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
0.336 (1, 16)
0.013 (1, 16)
0.013 (1, 16)

p
0.570
0.909
0.909

F (df)
0.86 (1, 16)
0.158 (1, 16)
0.86 (1, 16)

p
0.368
0.696
0.368

F (df)
0.164 (1, 16)
0.018 (1, 16)
0.018 (1, 16)

p
0.691
0.894
0.894

Table 22: Total Aggressive Acts
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
Table 23: Following Behavior
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level
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Figure 12. Mean latency to first face-to-face contact (A), total face-to-face and faceto-body contacts (B), and total aggressive acts and grids crossed while following (C)
in the social interaction test for IL1-R1 KO and WT mice. n = 5/group.
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Cognitive Functions
Morris Water Maze (MWM) Acquisition. A mixed Factorial ANOVA revealed a
significant overall main effect for the mean latency to find the platform across the different
testing blocks [F (1, 215) = 36.828, p = 0.001], indicating that animals learned across time. The
latency to escape varied by genotype, with a significant block by genotype interaction [F (1, 215)
= 2.881, p = 0.026], in which IL1-R1 KO animals were equivalent to WT animals in the first
testing block, but overall took longer to find the platform as the trial blocks progressed,
indicating impaired learning for the location of the platform. The IL1-R1 KO male animals
primarily drove this effect, as the KO females were very similar to the WT females and WT
males in the later trial blocks. There was no significant three-way trial block by genotype by sex
interaction [F (1, 215) = 0.876, p = 0.477], but there was a significant trial block by sex
interaction [F (1, 215) = 2.472, p = 0.048], with male animals showing overall longer latencies to
escape than female animals; however, this was again primarily driven by the IL1-R1 KO males,
who failed to show the same level of learning to find the platform across the later blocks. An
estimated measure of swim speed, based on the number of quadrant crossings made per trial
block, yielded a significant effect for trial block [F (1, 215) = 7.422, p = 0.001] and for trial
block by sex interaction [F (5, 215) = 3.533, p = 0.006], with female animals showing a faster
swimming speed as trials progressed while male animals did not show such an increase.
However, there was no trial block by genotype interaction [F (5, 215) = 1.383, p = 0.232], nor
block by genotype and sex interaction [F (5, 215) = 0.369, p = 0.848]. A separate ANOVA test
of the mean latency to find the platform on the first trial block revealed no genotype by sex
interaction [F (3, 41) = 0.508, p = 0.489], indicating no initial differences in performance. A
separate repeated measures ANCOVA was conducted to factor out the influence of estimated
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swim speed on the latency to find the platform across trial blocks, revealing a significant
genotype by trial block interaction [F (5, 185) = 2.626, p = .041} such that WTs performance
improved more quickly than the Kos. However, the previously significant sex by trial block
interaction effect was lost when estimated swim speed was covaried out of the analysis [F (5,
185) = 1.042, p = .185). The covariance analysis also revealed no three-way trial block by sex
and genotype interaction [F (5, 185) = 0.817, p = .509]. Therefore, when taking into account sex
differences in estimated swim speed, IL1-R1 KO animals had overall poorer learning for the
location of the platform as trials progressed when compared to WT animals.
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Figure 13. Mean latency to find the platform (A) and estimated swim speed (B)
across trial blocks during MWM acquisition for younger IL1-R1 KO and WT mice.
n = 11–12/group.

Morris Water Maze (MWM) Retention. IL1-R1 KO animals were found to spend
significantly less time in the goal quadrant than WT animals during a retention testing trial [F (1,
43) = 4.590, p = 0.038], with a significant genotype by sex interaction [F (1, 43) = 22.004, p =
0.001]. Similar to the findings in the MWM acquisition test, male IL1-R1 KO animals had poor
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retention for the location of the removed platform. This may reflect poor retention skills, but
more likely reflects a failure to learn the position of the platform in the original acquisition task.

Proportion of Time in
Goal Quadrant

There was no significant sex effect [F (1, 43) = 42.197, p = 0.146].
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Figure 14. Proportion of total time spent in the goal quadrant in MWM retention test
for younger IL1-R1 KO and WT mice. n = 11–12/group.

Object Placement. The proportion of time spent exploring the object in a novel location
did not differ across genotype [F (1, 42) = 0.118, p = 0.733] or sex [F (1, 42) = 1.975, p = 0.167],
and there was no significant genotype by sex interaction [F (1, 42) = 1.114, p = 0.297].
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Figure 15. Proportion of total time spent with a novel object in the object placement
test for IL1-R1 KO and WT mice. n = 11–12/group.

Discussion
Because IL-1 plays an important role in the inflammatory response, including sickness
behavior and changes in emotional and cognitive functions, IL1-R1 KO animals were tested on a
broad array of behavioral tests. Findings revealed that IL1-R1 KO animals have normal general
activity and locomotor functions, but some abnormalities in facial morphometry, as well as
selective cognitive and emotional abnormalities.
Consistent with prior research (e.g., Koo & Duman, 2009), IL1-R1 KO mice and WT
mice did not differ in their general locomotor activity, as measured by the total number of grids
crossed in the open field test. In addition, multiple gait measurements fell within a normal range.
However, facial morphometry measures revealed that KO animals having a shorter mean
palpebral fissure length. As a follow-up, animals were tested on the visual cliff apparatus and
were found to have normal depth perception. Therefore, although KO animals were found to
have smaller eyes, they appeared not to be blind and had no detectable visual impairment for
depth perception. Visual acuity was not tested, so it cannot be assumed KO animals have
completely normal visual functions. In addition to the smaller eye size, there was a non-
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significant trend for IL1-R1 KO animals to have a shortened philtrum length, indicating a shorter
snout. The findings of facial morphological abnormalities were not expected, but were consistent
with findings that IL-1 is important in prenatal development and postnatal bone growth (MacRae
et al., 2007).
IL1-R1 KO animals did not differ from WT animals in social behaviors. These findings are
important, as sickness behavior associated with increases in IL-1 activity includes a reduction in
social interactions (Bison et al., 2009). Thus, along with the failure to find general changes in
locomotion, we have ruled-out the influence of potential sickness-type behaviors in the WT animals
when interpreting other behavioral findings.
Generally, IL1-R1 KO animals were found have reduced anxiety levels across multiple
tests, most pronounced in male animals. However, findings were mixed across different measures of
anxiety-type behaviors. In the open field test, KO males were more similar to KO and WT females
than they were to WT males, who had a significantly longer latency to exit the center square. Male
KO animals were also found to have a reduced anxiety-type response in the novelty-suppressed
feeding test, where the drive to explore a food source is inhibited by the placement of the food in an
exposed open field. In this case, the KO male animals were found to enter the center of the open
field and either sniff or bite the food less often when compared to WT animals. Yet again, females
had the opposite response, with reduced center square entries and sniffs or bites of the food source,
consistent with a heightened anxiety response.
Both Koo and Duman (2009) and Murray et al. (2013) also found a decreased anxiety
response for IL1-R1 KO animals, but using different test measures. Koo and Duman found reduced
anxiety in male IL1-R1 KO animals in the elevated plus maze and the light-dark test. Murray found
reduced anxiety in both female and male IL1-R1 KO animals in the elevated plus maze and the
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open field test. Murray’s findings are also open to interpretation, as they found IL1-R1 KO animals
had more total grid crossings and rearing behaviors than WT animals, and failed to record measures
of activity in and out of the central grid square. In the context of finding a decreased anxiety
response in the elevated plus maze, they concluded the higher number of grid crossings and rearing
behavior were indicative of decreased anxiety. However, these behavioral patterns may also reflect
an overall increase in general activity instead of reduced anxiety.
The current study failed to reveal any significant differences for either the elevated plus
maze or the light-dark test of these behavioral tests, and only male IL1-R1 KO animals were found
to have a reduced anxiety-type response in the open field apparatus. While the pattern of results for
the male KO animals was consistent with prior reports; we were unable to fully replicate prior
findings. This may reflect differences in protocols, including the physical structure of the apparatus,
measurement tools, or animal ages, as Koo and Duman (2009) report their animals were adult
males, but do not provide specific ages.
Evaluation of depressive-type behavior also revealed a sex-specific genotype effect, as IL1R1 female KO animals spent more time immobile in the FST when compared to male KO animals
and both female and male WT animals. Koo and Duman (2009) failed to find a difference for WT
and IL1-R1 KO animals using a similar procedure, but only tested male animals. Our data replicate
their finding of no differences between male WT and male IL1-R1 KO animals on the FST, but
extend the findings to an observation that female KO animals have increased learned helplessnesslike behaviors.
IL1-R1 animals were found to have impaired learning and memory functions in the MWM.
During the acquisition phase, KO animals failed to learn to find the hidden platform, as indicated by
slower latencies in the later test trials. Sex-differences in this effect were apparent, but were no
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longer observed when an estimate of swim speed was covaried out of the analysis across all
animals. One interpretation of these findings is that KO animals had impaired locomotor functions
when swimming. In fact, there was a significant sex-difference in estimated swim speed, with
males swimming more slowly than females. However, there was no sex by genotype interaction for
swim speed, indicating the slowed latencies in the acquisition phase were not specific to KO males,
and further supported by the finding of an overall effect for genotype when swim speed estimates
were covaried out for the latency measure. Thus, the impaired learning for KO animals can
probably not be attributed fully to their slower swim speed. While the acquisition phase of the
MWM revealed no difference for male and female KO animals in their learning of the location of
the platform, performance in the retention phase indicate male KO animals had a more profound
learning impairment than females. Male KO animals showed no retention for the location of the
platform, which could indicate an impairment of memory processes, but more likely reflects an
initial impairment in learning the location of the platform in the acquisition phase. These
impairments in spatial learning and memory performance parallel those in prior findings with IL1R1 KO male mice (Avital et al., 2003), supporting Yirmiya et al.’s (2002) assertion of an optimal
level of IL-1 activity for normal spatial learning and memory functions, with impairments at both
abnormally low and high levels of IL-1 activity. It should be noted Murray et al. (2013) failed to
find impaired spatial learning in the MWM for female IL1-R1 KO animals. These findings are also
consistent with our findings, as male animals primarily drove the impaired learning and retention
performance observed for IL1-R1 KO animals.
A broad phenotyping battery of IL1-R1 KO animals revealed a pattern of overall decreased
anxiety behaviors, especially for males, and an increased depressive-type response in females, along
with impaired learning and memory functions for males. The finding of sex-based differences is
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particularly important, as most prior research on the importance of IL-1 activity for emotional
and cognitive behaviors in animals have been restricted to male-only or separated male and
female populations. At the same time, other research has pointed to consistent findings of sexbased differences in hippocampal function and stress responses in rodent populations (Falconer
& Galea, 2003; Shors et al., 2007). These differences could be attributed to a number of
potential factors such as differential developmental influences or the actions of circulating
gonadal hormones. Hormone-mediated differences are subject to change or resolution with
older-aged populations in which females experience decreases in levels of circulating ovarian
hormones (e.g., Brummelte & Galea, 2010). At the same time, aged populations are at an
increased risk for mood disorders and cognitive impairments (Kanowski, 1994; Korcyz &
Halperin, 2009). Given that aged populations are also at risk for increased neuroinflammation
(Cerejeirae et al., 2010), a second AIM of the current study focused on a specific subset of
behavioral tests to be tested on both male and female IL1-R1 KO animals at an older age.
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CHAPTER 4: SPECIFIC AIM 2
Specific Aim 2 was to explore potential age-related changes in learning and memory in male
and female IL1-R1 knock out (KO) mice, as well as for emotional differences found for
younger animals, to determine if impairments persist or worsen with age.
In Aim 1 a broad phenotyping battery showed that IL1-R1 KO mice differed from WT mice
in their emotional responses and cognitive functions. In addition, some of the effects were sexspecific or sex-preferential. KO mice showed a general pattern of reduced anxiety responses,
especially in males, while only female KO animals had increased depressive-type behaviors. IL1R1 KO mice also had impaired spatial learning and memory skills, again, with sex-based
differences. This pattern of findings was consistent with prior research testing male IL1-R1 KO
mice (e.g., Koo & Duman, 2008 & 2009), and the general finding that IL-1 activity is important for
optimal hippocampal function and regulation of immunological processes related to the stress
response (e.g., Dunn, 2000; Avital et al., 2003). However, the observed sex-based differences in
Aim 1 illuminate the potential importance of circulating ovarian hormones in helping to regulate or
modulate IL-1 activity, which has not been observed in prior studies with both male and female
IL1-R1 KO mice (Murray et al., 2013). In addition, prior studies have failed to look at changes in
performance across the lifespan. Badowska-Szalewksa et al. (2009) found an age-related decline in
IL-1 activity within the hippocampus and amygdala in a chronic stress response for rats,
highlighting the importance of studying the influence of IL-1 activity in older-aged animals.
The second Aim of the current study explored potential age-related changes in emotional
and cognitive functions in male and female IL1-R1 KO mice, by retesting animals on a subset of
behavioral tests with a minimum of six months between younger and older testing sessions.
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Specific Methods
Animals
Animals were retested between 11 and 13 months of age on the FST and the MWM test
(acquisition and retention phases).
Porsolt Forced-Swim Test (FST). A total of 11 IL1-R1 KO animals (6 male, 5 female)
and 11 WT animals (5 male, 6 female) were tested from a single cohort in the FST. Two
animals, one WT male and one IL1-R1 KO female, were excluded from testing at this age due to
illness or injury.
Morris Water Maze (MWM) Test. A total of 23 IL1-R1 KO animals (12 male, 11
female), and 22 WT animals (10 male, 12 female) were tested across two cohorts in the MWM
acquisition and retention trials. Two additional animals (WT males) were not tested due to the
presence of sores and diminished body weight suggestive of poor health or poor swimming
ability. The procedure for testing animals at the older age was the same, but with the platform
moved to a different quadrant to avoid the influence of any prior learning from previous testing
at a younger age.
Procedure
All behavioral testing procedures followed the same protocols outlined in Aim 1, unless
otherwise noted in the Results below.
Statistical Analyses
Univariate ANOVA tests were conducted on just the aged animals for each behavioral test
to assess for differences between KO and WT animals at an older age. Additional mixed Factorial
ANOVA tests were also conducted to compare younger and older aged animal testing performance,
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where possible. Appropriate alpha adjustments for significance testing were made to
accommodate for multiple testing.
Results
Emotional Responses
Porsolt Forced-Swim Test (FST). An initial ANOVA for the testing of the animals at
an older age revealed no significant effects for genotype [F (1, 24) = 0.641, p = 0.433], sex [F (1,
24) = 0.004, p = 0.949], or a genotype by sex interaction [F (1, 24) = 0.118, p = 0.735], see
Figure 16.
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Figure 16. Time spent immobile in the FST for older IL1-R1 KO and WT mice. n =

5–6/group.

A separate mixed Factorial ANOVA was conducted to compare the effects across the
different ages for testing. There were no significant main effects for age, genotype, or sex in the
time spent immobile on the second day in the apparatus (see Table 24). In addition, neither
genotype nor sex interacted significantly with age, or a significant age by genotype and sex
interaction (see Figure 17).
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Table 24: FST
Age
Genotype
Sex
Age x Genotype
Age x Sex
Age x Genotype x Sex
* significant at the p < .05 level

F (df)
0.593 (1, 18)
0.231 (1, 18)
0.770 (1, 18)
0.081 (1, 18)
3.641 (1, 18)
3.273 (1, 18)

p
0.451
0.637
0.392
0.780
0.072
0.087
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Figure 17. Time spent immobile in the FST for IL1-R1 KO and WT mice tested at

both a younger and an older age. n = 5–6/group.

Cognitive Functions
Morris Water Maze (MWM) Acquisition. A repeated measures ANOVA for just the
older aged animal testing trials yielded the expected significant overall main effect for trial block
[F (5, 205) = 15.377, p = 0.001], indicating that animals learned the location of the platform over
the course of the different trial blocks. There was also a significant block by genotype
interaction [F (5, 205) = 2.644, p = 0.034], with IL1-R1KO animals having longer latencies
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towards the later trial blocks, as well as a significant block by sex interaction effect [F (5, 205) =
4.637, p = 0.038], with male animals having longer latencies towards the later trial blocks. Both
the genotype and sex interaction effects with the trial block seemed to be driven by particularly
poor performance by the male IL1-R1 KO animals, but there was no significant trial block by
genotype by sex interaction [F (5, 205) = 1.133, p = 0.342], perhaps reflecting the large degree
of variability in performance across all groups. The overall pattern of results is similar to those
found for the same animals tested at a younger age (see AIM 1), but with a higher degree of
variability (see Figure 18). An estimated measure of swim speed, based on the number of
quadrant crossings made per trial block, yielded significant interactions for trial block by
genotype [F (5, 205) = 3.655, p = 0.009] and trial block by sex [F (5, 205) = 6.326, p = 0.001],
but no significant interaction of trial block by genotype by sex [F (5, 205) = 1.302, p = 0.264].
These findings show IL1-R1 animals had a slower estimated swim speed than WT animals, and
male animals swam more slowly than female animals (see Figure 19). A separate repeated
measures ANCOVA was conducted to factor out the influence of estimated swim speed on the
latency to find the platform across trial blocks. The previously significant genotype by trial
block interaction effect was lost when estimated swim speed was covaried out of the analysis [F
(5, 175) = 0.883, p = .476], as was the significant sex by trial block interaction [F (5, 175) =
2.347, p = .058]. The covariance analysis also revealed no three-way trial block by sex and
genotype interaction [F (5, 175) = 1.125, p = .347]. However, a separate ANOVA revealed no
significant genotype [F (1, 41] = 0.940, p = .338], sex [F (1, 41) = 0.297, p = .589], nor sex by
genotype interaction [F (1, 41) = 0.827, p = .368] effects for estimated swim speed in the first
trial block. Therefore, IL1-R1 KO animals had overall poor learning of the location of the

91
platform as trials progressed when compared to WT animals, but these effects also reflect a
reduced estimated swim speed for KO animals in later trials.
Therefore, there is no indication of an inherent swim deficit, and the slower swim speed
for the KO animals relative to the WT animals probably reflects a more aimless swimming
pattern when searching for the hidden platform. Overall, the pattern of findings is similar to
those found with the same animals when tested at a younger age, but with greater variability.

92
A
Mean Latency (secs.)

60

Older Animals

50
40

Male WT

30

Male KO

20

Female WT
Female KO

10
0
Early 1

Early 2 Middle 1 Middle 2
Block

End 1

End 2

B
Mean Latency (secs.)

60

Younger Animals

50
40

Male WT

30

Male KO

20

Female WT
Female KO

10
0
Early 1

Early 2 Middle 1 Middle 2
Block

End 1

End 2

Figure 18. Mean latency to find the platform for older (A) and younger (B) IL1-R1
KO and WT mice during MWM acquisition. n = Measurement for (A), and (B) (C)
for IL1-R1 KO and WT mice. n = 10–12/group.

93

Estimated Swim Speed

A
Older Animals

0.5
0.4

Male WT

0.3

Male KO

0.2

Female WT
Female KO

0.1
0
Early 1

Estimated Swim Speed

B

0.5

Early 2 Middle 1 Middle 2
Block

End 1

End 2

Younger Animals
Male WT

0.4

Male KO

0.3

Female WT

0.2

Female KO

0.1
0
Early 1

Early 2 Middle 1 Middle 2
Block

End 1

End 2

Figure 19. Estimated swim speed for older (A) and younger (B) IL1-R1 KO and WT
mice during MWM acquisition. n = 10-12/group.

Morris Water Maze (MWM) Retention. In an ANOVA test for just the older testing
session, IL1-R1 KO animals were found to spend significantly less time in the goal quadrant
during the probe trial than WT animals [F (1, 45) = 10.620, p = 0.002], similar to the effect
found during previous testing at a younger age (see AIM 1). While there was a significant
genotype by sex interaction for the animals at a young age (see AIM 1), the effect was not
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significant during the older aged test [F (1, 45) = 3.408, p = 0.072]. There was no main effect of
sex for the older animals [F (1, 45) = .256, p = 0.616].
A separate repeated measures ANOVA was conducted for the combined data from both
younger and older aged testing. There was a significant main effect of genotype, such that IL1R1 KO animals spent less time in the goal quadrant than WT animals (see Table 25), but no
significant main effects for age or sex. There were significant interactions between age,
genotype, and sex (see Table 25). An additional simple linear regression analysis was conducted
to predict older animal retention performance based on younger animal retention performance,
yielding a non-significant regression equation [F (1, 20) = 1.157, p = .295], with an R2 of .055
Table 25: MWM Retention
Age
Genotype
Sex
Age x Genotype
Age x Sex
Age x Genotype x Sex
* significant at the p < .05 level

F (df)
0.899 (1, 41)
13.538 (1, 41)
2.161 (1, 41)
1.476 (1, 41)
0.51 (1, 41)
2.214 (1, 41)

p
0.349
0.001*
0.149
0.231
0.479
0.144
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Figure 20. Proportion of total time spent in the goal quadrant in the MWM probe
retention trial for IL1-R1 KO and WT mice. n = 11-12/group.

Discussion
IL1-R1 KO mice were retested on a subset of behavioral tests that previously found to
reveal significant genotype and sex effects in emotional and cognitive functions to assess any
longitudinal changes across the lifespan. Some differences were observed with older IL1-R1 KO
animals, but with many of the prior effects being reduced or no longer present when compared to
the findings of Aim 1.
Testing of depressive-type behavior revealed no difference between IL1-R1 KO mice and
WT mice at an older age, nor any genotype or sex-based differences. Despite the finding of an
increased response in younger female KO animals in Aim 1, repeated tested at a later age
revealed no age-related differences. Generally, the lack of findings reflects issues of decreased
power and increased variability. Across all testing, older animals were more variable in their
performance, consistent with well-established findings of increased heterogeneity in rodent
behavior with aged animals (see van der Staay, 2002, for a review), due to a range of age-related
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factors that can variably affect developmental outcomes, including housing conditions,
sensorimotor impairments, and motivational factors. In addition, only one of the two cohorts
was tested at an older age in the FST, potentially leaving too small of a sample size to detect
differences due to insufficient power.
Older mice were also not found to differ in the learning of the location of a hidden
platform in the MWM. Previously, in Aim 1, genotype and sex effects were found for younger
animals, with impaired learning for IL1-R1 KO animals, especially males. A similar pattern was
observed with older animals, but failed to reach significance, due to the increased overall
variability of behavior in aged animals. It should also be noted for both the FST and the MWM
water temperature was not measured and may have varied with changes in room ambient
temperature across different test sessions.
Aging is associated with an increase in neuroinflammation, including increased IL-1
activity within the hippocampus, and has a negative impact on MWM performance (Moore et al.,
2009). IL1-R1 KO animals may have a reduced inflammatory response when aging due to their
impaired IL-1 activity, as reflected in the similar flat learning curve found for the IL1-R1 KO
males for both younger and older aged MWM acquisition performance. On the other hand, the
possible protective functions of circulating ovarian hormones may be on the decline in the older
females, but not sufficiently low enough to impair learning performance in the older IL1-R1 KO
animals. In fact, animals in the current study were age 11 to 12 months at the time of retesting in
the MWM, and prior research has indicated C57BL/6J female mice do not reach complete loss of
the estrous cycle until 13-18 months, on average (Frick, Burlingame, Delaney, & BergerSweeney, 2002). This same point may also be significant in interpreting the previous finding of
no increase in depressive-type behaviors in older IL1-R1 KO female mice. That is, it is possible
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that the elevated learned hormone-related mediators drove helplessness-like response of the
younger KO females.
While IL1-R1 KO animals were not found to have overall significantly impaired learned
performance in the older test trials, they did have a significantly impaired performance in the
retention phase of the MWM task. Typically, unimpaired acquisition and impaired retention
would indicate a problem with the retention of a spatial memory. In this instance the results are
not as clear, as younger IL1-R1 KO animals had a similar pattern of poor retention after an
impaired learning trial, consistent with never having learned the location of the platform.
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CHAPTER 5: SPECIFIC AIM 3
Specific Aim 3 was to investigate possible neuroanatomical effects of IL1-R1 null mutation,
including differences in gross anatomy and morphology and distribution of microglial cell
populations and vasculature in the hippocampus.
In the first two Aims of the current thesis, IL1-R1 KO animals were found to differ from
WT animals on behavioral measures of anxiety, depression and spatial learning and memory.
Repeated testing at a later age revealed increased heterogeneity in performance, reducing the
statistical magnitude of the differences between KO and WT animals. Despite this increased
variability across all groups, there was still evidence of impaired spatial memory performance for
IL1-RI KO animals. Importantly, genotype differences were also found to be sex-dependent in
several measures, especially for younger animals. In a third Aim, to better understand the nature of
the noted behavioral changes, neuroanatomical measures were assessed and correlated to specific
behavioral findings.
First, gross anatomy of the brain and gross structural organization of hippocampal regions
were evaluated to assess any notable differences between IL1-R1 KO animals and WT animals, also
taking into consideration any sex differences. Previously Murray et al. (2013) found no differences
between IL1-R1 KO mice and WT mice in ventricular volume, but the researchers were limited to
looking at the brains of six animals, and all were female.
Second, vascular morphology and investment were assessed. Both pathogen-induced and
age-related increases in neuroinflammatory levels have been associated with changes in
cerebrovascular functioning, and vascular insufficiency has been reported in humans with cognitive
or depressive symptoms (see Fountoulakis, Siamouli, Magiria, & Kaprinis, 2007, for a review). It
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is therefore reasonable to hypothesize that IL1-R1 KO animals found to have altered cognitive and
emotional behavior patterns may also display atypical hippocampal vasculature.
Third, general morphology and distribution of microglial cell populations within the
hippocampus were assessed. Microglia play a significant role in the production and regulation of
IL-1β in the CNS, acting as both a target and source of IL-1β activity. In their active state,
microglia have a larger cell body with shorter processes (Dheen, Kaur, & Ling, 2007), and express
caspase-1, the enzyme critical for cleaving pro-IL-1 into its active form (Erikkson et al., 1999).
Circulating IL-1β is then able to continue activating microglia through the IL-1 receptors found on
the surface of microglia, producing a type of feedback loop for increasing IL-1 levels beyond the
initial acute stage of inflammation (Kaushik, Thounaojam, Kumawat, Gupta, & Basu, 2013). Given
that normal aging is associated with an increased neuroinflammatory state, including an increase in
circulating IL-1β, it is not surprising healthy aged individuals are also found to have an increase in
activated microglia populations (Dilger & Johnson, 2008). This increase in base level of activated
microglia could contribute to the increased vulnerability to cognitive impairment and disease among
aged populations (Dilger & Johnson, 2008). In fact, it has been suggested that microglia directly
contribute to the cognitive decline associated with not only normal healthy aging, but also
dementing conditions (Li, Liu, Barger, & Griffin, 2003). Autopsies of AD patients have found
amyloid plaques, the hallmark of AD, are often surrounded by fields of activated microglia
(Perlmutter, Scott, Barrón, & Chui, 1997). These microglia have been suggested to play a
significant role in the development of the amyloid plaques through the release of IL-1 that
contributes to tau phosphorylation central to plaque formation (Li, Liu, Barger, & Griffin 2003).
Given that IL1-R1 KO animals have reduced cytokine (i.e. IL-1) activity, it may be expected they
would have fewer activated microglia, helping to explain the impaired learning and memory
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performance of these animals. Prior research found no differences between WT and IL1-R1 KO
male mice in the early activation of microglia following the introduction of chemically induced
injury to the hippocampus (Harry, Funk, d’Hellencourt, McPherson, & Aoyama, 2008). However,
these researchers only studied weanling male animals and did not look at hippocampal regions of
animals that did not undergo a surgical procedure.
Specific Methods
Animal Sacrifices
Animals were deeply anesthetized and overdosed with chloral hydrate-pentobarbital,
exsanguinated, and perfused transcardially with heparinized 0.9% saline followed by 4%
paraformaldehyde, first in acetate buffer (pH 6.5) and then 4% paraformaldehyde in borate
buffer (pH 9.5). After fixation, brains were removed and post-fixed overnight before being
transferred to 30% sucrose in borate buffer at 4° C for three to ten days.
Tissue Processing
Following immersion in the sucrose borate buffer solution, brains were frozen and
coronally sectioned at 50 µm on a sliding microtome and stored at -20° C in cryoprotectant
solution as in Watson, Wiegand, Clough, and Hoffman (1986).
Histology
Mouse brain sections were mounted on gelatin-coated slides and allowed to dry for three
days. Slides were stained using the manual regressive Hematoxylin and Eosin (H&E) method
for visualizing general tissue structure. Slides were dipped in a xylenes solution, dehydrated in
ethyl alcohol, and rehydrated in tap water before staining in Harris Hematoxylin. Tissue was
then rinsed in tap water, dehydrated in ethanol, and rehydrated in tap water with a rinse in 0.25%
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ammonia water prior to counterstaining in 1% eosin solution. Finally, tissue was dehydrated in
ethanol and xylenes prior to coverslipping.
Immunohistochemistry
Mouse brains were immunostained to visualize the microglial marker ionized calcium
binding adapter molecule 1 (Iba1), using a rabbit polyclonal primary antibody against Iba1
(1:1000 dilution; Millipore) and a biotinylated goat anti-rabbit secondary antibody (Vector
Labs). Microglia were visualized using a diaminobenzidine (DAB) chromagen and a Vector Elite
ABC kit (Vector Labs). Stained sections were then mounted on gelatin-coated slides, which were
dehydrated in graded ethanols and cover-slipped after immersion in xylenes.
Tissue Analysis
Image Capturing and Analysis. Stained sections were placed under a Zeiss light
microscope, and the hippocampal region was viewed and images were captured using Spot
Digital Imaging software (Diagnostic Instruments, Sterling Heights, MI). Quantitative image
analysis was conducted using Image J software (National Institutes of Health, Bethesda, MD).
Gross Anatomy and Structural Abnormalities of Hippocampal Regions. H&E
stained cross-sections of the brain at the level of the hippocampus were observed for gross
structural abnormalities for each animal in the second testing cohort, for a total of 11 WT (6
male, 5 female) and 7 IL1-R1 KO (3 male, 4 female) animals.
Vasculature of Hippocampal Regions. H&E stained sections of the hippocampal
region, including the Dentate Gyrus (DG) and region CA1, were evaluated for each animal in the
second testing cohort, for a total of 11 WT (6 male, 5 female) and 7 IL1-R1 KO (3 male, 4
female) animals. Images were analyzed for four vascular parameters. The median vessel
diameter was calculated for each animal, measuring the minimal diameter (in microns) of vessels
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cut across a transverse plane in coronal sections, indicating rostral-caudal coursing vasculature.
In addition, the minimal diameters were determined across the width of longitudinally oriented
vessels in the same plane, which consisted of dorsal-ventral or medial-lateral coursing vessels.
The total number of sampled blood vessels (both transverse/coronal cut vessels and blood vessels
running longitudinally) was calculated for each animal using point-count stereology. In addition,
the proportion of transverse cut vessels with visible intrusion of cells (i.e. infiltrates) within the
lumen of the vessels was calculated for each animal. This measure was included to look for
possible evidence of leukocyte migration across the BBB, which has been found in several
neurological conditions, including MS and other autoimmune disorders (see Takeshita &
Ransohoff, 2012, for a review).
Microglia Populations and Morphology. Iba1 immunostained sections of the
hippocampal region, including the Dentate Gyrus (DG) and region CA1, were evaluated for each
animal in the second testing cohort, for a total of 12 WT (6 male, 6 female) and 10 IL1-R1 KO (5
male, 5 female) animals. A total count of labeled microglia contained within the focal plane for
one pseudorandomly selected focal plane in one section was calculated in each region for each
animal using the Cell Counter Tool in Image J software. Randomly selected high magnification
fields of areas within both the CA1 and the DG regions within the original field were sampled
for each animal. Microglial cell soma areas (in squared microns) were measured for each
animal, for all visible labeled cells within the visual field, with separate calculations for the DG
and region CA1.
Statistical Analyses. Histological measures for vasculature and microglia were analyzed
for genotype and sex differences, as well as for genotype by sex interactions using separate
univariate ANOVA tests. Appropriate alpha adjustments for significant testing were made to
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accommodate for multiple testing. In addition, all histology measures were correlated with
behavioral test results associated with significant findings in AIMs I and II. To test for
correlations with depressive-type behavior, histological measures were correlated with time
spent immobile on day two of testing, for both younger and older animal test groups. To test for
correlations with learning and memory performance, histological measures were correlated with
final trial block latencies to find the hidden platform for both younger and older test groups, as
well as the proportion of time spent in the goal quadrant during the MWM probe-trial retention
test, again for both younger and older animals.
Results
Gross Anatomy and Structural Abnormalities of Hippocampal Regions
There were no noticeable differences in gross anatomy (see Figure 21), or any differences
in overall hippocampal structure across the different groups (see Figure 22).
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Figure 21. Representative samples of H&E stained coronal slice of male WT (A), female WT
(B), male IL1-R1 KO (C), and female IL1-R1 KO (D) mouse brains. Magnification = 1X
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Figure 22. Representative samples of H&E stained coronal slice of the hippocampal
region for male WT (A), female WT (B), male IL1-R1 KO (C), and female IL1-R1 KO (D)
mouse brains. Magnification = 5X

Vasculature of Hippocampal Regions
There was a significant genotype effect for the total number of blood vessels (transverse
cut and longitudinal vessels) within the hippocampus, with WT animals having a higher overall
vascular investment than KO animals (see Table 26 and Figures 23–24). There were no
significant effects of sex, nor any genotype by sex interactions for the vascular count measure.
In addition, there were no significant main effects of genotype or sex, or significant genotype by
sex interactions for either vessel diameter (see Table 27 and Figure 24) or the presence of
infiltrating intravascular cells (see Table 28 and Figure 24).
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Table 26: Total Blood Vessels per Frame
F (df)
Genotype
9.121 (1, 18)
Sex
0.147 (1, 18)
Genotype* x Sex
0.355 (1, 18)
* significant at the p < .05 level

p
0.009*
0.708
0.561

Table 27: Median Vessel Diameter
Genotype
Sex
Genotype x Sex
* significant at the p < .05 level

F (df)
1.863 (1, 18)
0.808 (1, 18)
0.471 (1, 18)

p
0.194
0.384
0.504

Table 28: Proportion of Vessels with Infiltrating Cells
F (df)
p
Genotype
0.495 (1, 18) 0.493
Sex
1.046 (1, 18) 0.324
Genotype x Sex
0.004 (1, 18) 0.952
* significant at the p < .05 level

A

B

WT
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Figure 23. Representative samples of vascular investment in the hippocampal region
for WT (A) and IL1-R1 KO (B) mice. Magnification = 20X
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Figure 24. Mean total number of blood vessels observed in a single image taken from the
hippocampal region of IL1-R1 KO and WT mice (A), the average median diameter of
observed blood vessels within the same region (B), and the proportion of blood vessels
observed in these same regions presenting with infiltrating cells (C). n = 3–6/group.

Each vascular measure was tested for a significant correlation with behavioral measures
associated with prior significant findings in AIMs 1 and 2 (see Table 29). There was a
significant correlation between the total number of vessels in the hippocampus and the
proportion of time spent in the goal quadrant during the MWM retention probe trial for older
animals (see Figure 25). Animals with greater vascularization of the hippocampus had better
retention for the location of the platform when tested at an older age. When broken down by

108
genotype, the correlation of the total count of blood vessels to MWM retention performance was
stronger for IL1-R1 KO animals [r (6) = .70)} than WT animals [r (7) = .55], though the
difference between the two correlations was not significant (Z = 0.411, p = .681).
There were no significant correlations between depressive-type behavior in either
younger or older animals and any of the vascular measures (see Table 29).
Table 29: Correlations between Vascular Histology and Behavioral Measures
Microglia Measures
Proportion
Total
Median Vessel
Vessels with
Behavioral Measures
Vessels
Diameter
Infiltrating Cells
Younger FST Immobile
Time r (18) = .128
r (18) = .297
r (18) = -.104
p = .612
p = .232
p = .682
Older FST Immobile Time r (17) = -.043
r (17) = -.226
r (17) = -.356
p = .870
p = .384
p = .161
Younger MWM Final r (18) = -.164
r (18) = -.284
r (18) = -.019
Block Latency
p = .515
p = .253
p = .941
Younger MWM Retention r (18) = .040
r (18) = .296
r (18) = -.171
p = .874
p = .233
p = .498
Older MWM Final r (17) = .044
r (17) = .228
r (17) = -.041
Block Latency
p = .868
p = .379
p = .875
Older MWM Retention r (17) = .535
r (17) = .035
r (17) = -.048
p = .027*
p = .893
p = .855
* significant at the p < .05 level
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Figure 25. Correlation between the proportion of time spent in the goal quadrant
during the MWM probe retention trial and the total number of blood vessels observed
in a coronal slice of the hippocampal region for IL1-R1 KO and WT mice. n = 17.

Microglia Populations and Morphology
IL1-R1 KO animals were not found to significantly differ from WT animals in the
number of microglia in observed hippocampal sections [F (1, 22) = 1.186, p = 0.062], nor was
there a significant effect for sex [F (1, 22) = 7.359, p = 0.290] or a significant genotype by sex
interaction [F (1, 22) = 0.336, p = 0.569], see Figures 26–27. The average of individual animal
median microglia cells size in both the DG and region CA1 of the hippocampus were found not
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to differ by genotype or sex, with no genotype by sex interactions (see Tables 30–31 and Figure
28).
Table 30: Median Microglia Cell Body Area
in the Dentate Gyrus
F (df)
Genotype
3.128 (1, 22)
Sex
2.976 (1, 22)
Genotype x Sex
0.076 (1, 22)
* significant at the p < .05 level
Table 31: Median Microglia Cell Body Area
in Region CA1!
F (df)
Genotype
0.154 (1, 22)
Sex
1.875 (1, 22)
Genotype x Sex
0.851 (1, 22)
* significant at the p < .05 level

p
0.094
0.102
0.786

p
0.699
0.188
0.368

111
Dentate Gyrus
A

B

WT

KO

CA1
C

D

WT

KO

Figure 26. Representative samples of Iba1 stained microglia within the DG of WT (A), and
IL1-R1 KO mice (B), and within region CA1 of WT (C) and KO mice (D). Magnification =
20X
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Figure 27. Mean total count of microglia observed in a coronal slice of the
hippocampal region of IL1-R1 KO and WT mice. n = 5–6/group.
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Figure 28. Mean of median cell body size of microglia in the Dentate Gyrus (A) and
region CA1 (B) of the hippocampus for IL1-R1 KO and WT mice. n = 5–6/group.

Each microglia measure was tested for a significant correlation with behavioral measures
associated with prior significant findings in AIMs 1 and 2, with no significant correlations
revealed (see Table 32).
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Table 32: Correlations between Microglia Histology and Behavioral Measures
Microglia Measures
Total
CA1 Median
DG Median
Behavioral Measures
Microglia
Cell Size
Cell Size
Younger FST Immobile
Time r (22) = -.195
r (22) = -.301
r (22) = -.159
p = .383
p = .174
p = .478
Older FST Immobile Time r (21) = .169
r (21) = .200
r (21) = .220
p = .465
p = .385
p = .338
Younger MWM Final r (22) = .262
r (22) = -.037
r (22) = .194
Block Latency
p = .239
p = .870
p = .387
Younger MWM Retention r (22) = .036
r (22) = -.012
r (22) = -.058
p = .875
p = .956
p = .797
Older MWM Final r (21) = .044
r (21) = .067
r (21) = .183
Block Latency
p = .850
p = .773
p = .428
Older MWM Retention r (21) = -.094
r (21) = .061
r (21) = -.227
p = .684
p = .792
p = .321
* significant at the p < .05 level
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Discussion
Neuroanatomical measures revealed no gross differences in cortical size nor structure,
nor in hippocampal structure between IL1-R1 KO mice and WT animals. However, IL1-R1 KO
animals did have significantly reduced vascular investment in the hippocampal region, a
difference that was found to correlate with cognitive performance in older animals. The changes
in vasculature were not accompanied by significant differences in microglial cell populations.
The reduced vascularization observed in IL1-R1 KO animals may reflect the influence of
IL-1 activity on the upregulation of vascular endothelial growth factor (VEGF), a driving force
in angiogenesis. IL-1β initiates angiogenesis by recruiting endothelial cells to produce VEGF,
with then promotes the growth of new capillaries from pre-existing blood vessels (see Voronov,
Carmi, & Apte, 2014, for a review). Reductions in VEGF activity and associated loss or
reduction in angiogenesis has been observed in both ischemic hindlimb injury (Amano et al.,
2004) and tumor growth (Carmi et al., 2009) studies using IL1-R1 KO animals. Thus, it is
possible in the current study that the lack of IL-1 activity in IL1-R1 KO animals contributed to a
loss of normal vascular functions, including in the hippocampus.
We specifically found decreased vascularization in region CA1 and the nearby
hippocampal fissure that was correlated with impaired spatial learning and memory performance
for older animals, as well as an overall impairment in learning and memory performance in older
IL1-R1 KO animals that also had a reduced vascular presence in these regions. Because of the
relatively high concentration of NMDA receptors in area CA1 it is particularly susceptible to
excitotoxic damage associated with hypoxia and ischemia of vascular disease. On the other hand,
the DG is relatively less susceptible to vascular disease and more sensitive to corticosteroid
changes because of a high concentration of glucocorticoid receptors. Small and colleagues
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(2011) propose a functional model of hippocampal circuitry in which the more vascular sensitive
CA1 region is critical for integrating input from the entorhinal cortex and CA3, helping with the
formation of allocentric spatial maps, and making this region critical for learning in tasks such as
the MWM.
Both normal aging animals and AD model animals are found to have reduced capillary
loss and impaired angiogenesis functions, resulting in decreases in microvascular densities
within the hippocampus. These reductions in cerebral perfusion are consistently associated with
degrees of impairment in dementing conditions (see Brown & Thore, 2011, for a review).
Taking into account what is known about IL-1’s contribution to VEGF-related angiogenesis, and
the normal age-related increase in neuroinflammation and impaired neurogenesis, the current
study may provide evidence of IL-1 playing a protective role in the preservation of hippocampal
function through the promotion of angiogenesis. In the case of IL1-R1 KO animals, which
presumably would be somewhat spared the normal age-related increase in neuroinflammation,
but also miss out on the associated increase in VEGF-related angiogenesis. Thus, our observed
reduction of vascularization in the hippocampus for IL1-R1 KO animals is not surprising. In
addition, the significant correlation between vascular counts and impaired MWM performance is
consistent with above-noted findings of learning and memory impairments observed in clinical
populations with reduced hippocampal vascularization..
The current findings revealed no significant correlation between depressive-type behavior
and vascular differences. It is plausible to expect decreased vascularization in animals with
poorer learning and memory performance, given the recognized link in vascular depressive
conditions (e.g., Alexopolous et al., 1997). Unlike models of vascular dementia and AD, in
which specific changes in hippocampal vasculature have been noted, vascular depression models
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have typically associated depressive conditions to more widespread changes in vascular
functioning and focus on cortical and subcortical structures (Taylor et al., 2013). Thus, by
limiting the observation of vascular changes to post-mortem vascular count and diameter in the
CA1 region of the hippocampus, we have failed to evaluate more global or dynamic changes in
cerebral blood flow, and therefore cannot rule out the possibility of blood flow changes as an
underlying factor in depressive-like behaviors based on the methods used in the current study. In
addition, although our female KO animals exhibited depressive-like behaviors when they were
young, they no longer showed these behaviors when they were older, which is when tissue was
collected.
Finally, the current study failed to reveal significant differences in either the number or
size of microglia for IL1-R1 KO versus WT animals. It is important to note the Iba1 stain does
not specifically label activated microglia. However, morphological changes in microglia shape
and size have previously been validated as a measure for recognizing microglia activation
following LPS injections (Kozlowski & Weimer, 2012). The finding of no genotype effect in the
soma size for microglia is unexpected, as prior research has indicated that IL1 plays an important
role in neuroimmune activity, including the activation of microglia (e.g., Chung et al., 2010). In
addition, since increases in IL-1 activity are associated with increases in activated microglia,
especially for aged populations (Bay-Richter et al., 2011; Dilger & Johnson, 2008), there is the
possibility that the impaired IL-1 activity in IL1-R1KO animals would protect them from typical
age-related increases in activated microglia. However, the protective effects of a reduction in IL1 activity may only be observable with an additional stressor or pathogen that increases
neuroinflammation in WT mice but possibly sparing IL1-R1 KO mice. This possibility has been
tested previously with very young (25-30 day-old) male IL1-R1 KO mice, which also revealed
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no genotype effects in the presence of activated microglia within the hippocampus following
LPS injections (Harry et al., 2008). This does not rule out the possibility an effect could be
found with older animals. It should also be noted, the current study was limited to testing a
small sample for the histology measures (only one cohort), This, along with the high degree of
heterogeneity of behavioral testing in older animals, may have reduced power levels enough to
prevent reaching significance for both tests of differences in genotypes and neurobehavioral
correlates. In addition, IL1-R1 KO animals have a deficiency specific to IL-1 activity, leaving
the possibility for compensatory actions associated with other cytokines, such as IL-6 and TNFα. In fact, Bluthé et al. (2000) have previously shown TNF-α can replace IL-1 in IL1-R1 KO
mice following an LPS injection. Finally, in the current study we only evaluated microglial size
and investment, and so cannot rule out the possibility that differences in microglial function were
present and contributed to behavioral effects.
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CHAPTER 6: GENERAL DISCUSSION
IL1-R1 KO animals were tested across a wide range of behavioral tests at two different
ages. The most prominent behavioral finding was a sex-specific impairment in spatial learning
and memory performance such that IL1-R1 KO males were significantly impaired in MWM
acquisition and retention relative to either female KO animals or WT animals of either sex.
More minor changes in emotional processing, including anxiety and depressive-type responses,
were observed, and findings of mild increases in depressive and anxious-like behaviors were
only present in female KOs, suggesting a different profile of behavioral impairments in male
versus female KO mice. In addition, although the brains of IL1-R1 KO animals were grossly
normal, they were found to have reduced hippocampal vasculature, which was significantly
correlated with the observed cognitive abnormalities.
The Importance of IL-1 Activity for Cognitive Behavior
Previously, the link between IL-1 activity and learning and memory performance in
human research and clinical populations has been mixed, in part due to differences in research
protocols and limitations in experimental control (Vollmer-Conna et al., 2004). However, the
overall pattern has shown that increased cytokine activity, including increased IL-1, is linked to
impairments in cognitive performance. Increased levels of circulating IL-1β in patients with AD
and in healthy individuals exposed to an acute stressor have been linked to impaired performance
across multiple cognitive tasks (Forlenza et al., 2009; Krabbe et al., 2005). Research with
animals has helped to more clearly establish the link between IL-1 activity and changes in
cognitive function, suggesting an optimal level of IL-1 activity is critical for normal
hippocampal-dependent spatial learning and memory functions. Rather than just the mere
presence or absence of IL-1, Gibertini (1998) proposes that either abnormally high or low levels
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of IL-1 activity can have a negative impact on hippocampal function. For example, animals
injected with the bacterial component lipopolysaccharide (LPS) had an increase in IL-1 activity
that directly corresponded to decreases in MWM learning performance (Oitzl et al., 1993).
While Murray et al. (2013) found no impairments in MWM performance for female IL1-R1 KO
animals, Avital et al. (2003) found male IL1-R1 KO mice had impaired learning performance in
the MWM (Avital et al., 2003). These MWM effects are specific to hippocampally-mediated
spatial learning and memory performance, while non-spatial performance is typically spared
(Moore et al., 2009; Avital et al., 2003; Murray et al., 2013). Increased cytokine activity,
whether stress-induced, age-related, or triggered by the introduction of a pathogen, has been
linked to impaired hippocampal learning mechanisms, including reductions in neurogenesis and
LTP processes, especially in the CA1 region (Oitzl et al., 1993; Koo & Duman, 2008; Ross et al.,
2003; Chugh et al., 2013; Murray & Lynch, 1998). In addition, IL-1 specifically has been
identified as important in the upregulation of VEGF-related angiogenesis (Amano et al., 2004).
The angiogenic influence of VEGF within the hippocampus is also associated with hippocampal
neurogenesis (see Ruiz de Almodovar, Lambrechts, Mazzone, & Carmeliet, 2009, for a review).
Thus, it is possible the current findings related to impaired spatial learning and memory, as well
as depressive-type behaviors in IL1-R1 KO mice may reflect an impact on VEGF-related
angiogenesis within the hippocampus. This theory is also supported by our finding of a
significant correlation between reduced vasculature in the hippocampus and poorer MWM
retention performance in older animals.
The current study further supports the theory that normal IL-1 signaling is necessary for
optimal hippocampally-mediated spatial learning and memory functions, as male IL1-R1 KO
animals were impaired in the acquisition and retention of a hidden platform in the MWM. The
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difference between groups was stronger at the younger testing age, and was only present in the
male animals. In fact, at the older age of testing, overall learning performance differences were
statistically attenuated by the increase in behavioral variability that is typical with aging animals
(van der Staay, 2002). Poor memory retention in the MWM could simply reflect a failure of
learning, because memory for a task cannot be retained if it is never acquired. The finding of a
stronger impairment in learning and memory performance for male IL1-R1 KO animals when
compared to female IL1-R1 KO animals is a novel, though Murray et al. (2013) also found no
impairment in MWM performance in testing with only female IL1-R1 KO animals. The
mechanism underlying the preservation of learning in female IL1-R1 KO mice is unknown, but
could reflect a protective function of ovarian hormones in the hippocampus, preventing acute and
chronic stress-related anti-neurogenesis (Falconer & Galea, 2003; Westenbroek et al., 2004). It
is also possible that the female KOs had an increased motivation to solve the maze task because
of their mildly elevated anxiety. This explanation seems unlikely, however, given their tendency
toward learned helplessness in the FST, which would be counterproductive in the MWM task.
Generally, the current findings are consistent with prior research indicating that an
optimal level of IL-1 activity is required for optimal spatial learning and memory functions.
Although the mechanisms underlying the impairment in learning are unknown, the finding of a
significant correlation between learning performance and vascular investment suggests that
impaired hippocampal perfusion could have been a contributory or related factor. More work
will need to be done to determine whether the relationship between learning and vascular
investment in these mice is causal or merely correlational. In addition, studies of the vasculature
in developing IL1-R1 KO mice would help to answer the question of whether the IL-1 signaling
deficiency leads to poor vascular development or a failure of later sprouting, compensatory
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vascular enrichment, or vascular retention, and the possible role of VEGF in helping to regulate
these processes
The Importance of IL-1 Activity for Emotional Behavior
In addition, to learning, IL-1 activity has also been linked to stress responses and anxiety.
These links have primarily been described in research conducted with endogenous increases in
cytokine activity. For example, in one study, healthy young adults were exposed to a cognitive
stressor. Those who reported the greatest increase in feelings of anxiety also had the greatest
changes in circulating IL-1β levels (Maes et al., 1998). Similar findings have been described
with clinical populations who have atypically strong increases in IL-1β activity in response to
environmental stressors and report associated feelings of overwhelming anxiety, such as in
patients with PTSD (Spivak et al, 1997). In addition, animal research into anxiety-related
behaviors, focusing on approach and exploratory drives, have found that increased IL-1β levels
are associated with increased anxiety-like behaviors, such as a reduced exploratory drive and
neophobia (e.g., Swiergiel & Dunn, 2007). Conversely, male IL1-R1 KO animals have been
noted to have a reduction in anxiety-type behaviors when exposed to a series of chronic stressors
(Koo and Duman, 2009), a finding that we have not replicated at a statistically significant level.
Indeed, while we never observe significant decreases in anxiety-related behaviors in our male
IL1-R1 KO animals, we do observe that their mean scores are always lower than those of their
WT counterparts in measures of anxiety-like behaviors (i.e. light-dark task, elevated plus maze,
open field center square).
Despite the consistent finding of a link between anxiety and IL-1 activity, the relationship
between neuroinflammatory mechanisms and the stress response is highly complex. There are
differences in the presence and strength of effects for different types of stressors, the duration of
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a stressor, and the different types of behavioral test measures (Murray & Lynch, 1998; PlataSalamán et al., 2000; Badowska-Szalewska et al., 2009). Similarly, the findings in the current
study were mixed. Although a reduction in anxiety-type behaviors was observed for male IL1R1 KO animals in the open field test and novelty-suppressed feeding test, the female animals do
not show a similar pattern of anxiety-related behaviors. For example, while female IL1-R1 KO
animals were similar to their male counterparts in having a reduced anxiety response in the open
field test, they were more like WT male animals in the novelty-suppressed feeding test. In
addition, neither male nor female IL1-R1 KO animals differed from WT animals in the lightdark test. Thus, the current findings, while generally consistent with prior findings of a reduced
anxiety response in male IL1-R1 KO animals, further complicate understanding the role of IL-1
in anxiety-related behaviors. It is possible IL1-R1 KO males have an accelerated decline in
anxiety-related behaviors that are observable in younger animals, while females may be delayed
or experience a more gradual decline associated with decreased hippocampal efficiency. But this
interpretation is limited given Murray et al. (2013) were able to find reduced anxiety-type
behaviors in young adult female IL1-R1 KO animals in the elevated plus maze. Also important,
the current battery of tests did not directly test the difference between chronic and acute
stressors, which are also known to vary in their effects across different ages and by sex
(Badowska-Szalewska et al, 2009; Yee & Prendergast, 2010).
Researchers originally explored the link between depressive conditions and IL-1 in the
1950s, studying increases in cytokine activity and related sickness behavior, including loss of
appetite, feelings of malaise, and social withdrawal (see Dantzer & Kelly, 2007, for a review). A
half-century later, with the development of new behavioral testing paradigms and antidepressant
medication, research began to take a closer look at the potential relationship between IL-1
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activity and depression (Yirmiya et al., 1999). In fact, people with cytokine-related illnesses will
often report feelings of depression (e.g. Whalley et al., 2007), and some individuals diagnosed
with clinical depressive conditions with no comorbid medical conditions have also been found to
have increased inflammatory activity (e.g., Owen et al., 2001).
However, depressive conditions are distinct from a sickness behavioral response, but
happen to share underlying related symptomatology and links to changes in neuroinflammation
and stress-related changes in HPA axis activation. For example, IL-1 activity has been shown to
be critical for the development of anhedonic-type behaviors following chronic stress exposure
(Koo & Duman, 2008). However, in more traditional learned-helplessness models of depressive
behavior testing, the findings have been inconsistent. In one set of studies IL-1 activity was
found to be critical for the development of a depressive-type response to a painful stressor
(Maier & Watkins, 1995), while Koo and Duman (2009) found IL1-R1 KO mice did not differ
from WT animals in depressive-type behavior during the FST. Similar to Koo and Duman, the
young male IL1-R1 KO animals did not differ from their young male WT counterparts in the
FST. However, the inclusion of females in the current study revealed an increase in depressivetype behaviors for female IL1-R1 KO animals, but only at the younger age of testing. The link
between a loss of normal IL-1 activity in IL1-R1 female KO mice and an increase in depressivetype behavior in the FST is unclear, especially given prior findings that female rats injected with
LPS leading to an enhanced HPA axis response also had a decrease in depressive-type behavior
in the FST (Pitychoutis et al., 2009). These researchers also noted an increase in serotonin
activity, and suggested a sex-specific coping style that results in reductions depressive-type
behavior.
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In addition, there is a general concern regarding factors that may influence FST
behaviors, including species, sex, and strain differences. For example, rats typically require two
training episodes before developing an immobility response during the test phase of the test,
while mice require only one training episode (see Bogdanova, Kanekar, D’Anci, & Renshaw,
2013, for a review). Also, female rats have been shown to be more sensitive to picking up a
depressive-type response to the FST than male rats (Dalla, Pitychoutis, Kokras, &
Popadopoulou-Daidfoti, 2011), while others have found sex-differences among mice to be straindependent (see Petit-Demouliere, Chenu, & Bourin, 2005, for a review). Thus, our findings of a
sex-based difference in a mutant mouse strain may not be comparable to prior research
conducted in rats. Finally, extensive research has found a high degree of variability across
different mouse strains in the development of a depressive-type response in the FST (see Cryan
& Mombereau, 2004, for a review). The C57/BL6 mouse strain we tested is known to have a
moderate to strong responsiveness to this test, but have failed to specifically compare male and
female animals (e.g., Matsuo et al., 2010). Therefore, the interpretation of our findings is limited
and requires further exploration with both WT and KO animals.
FST findings are often subject to scrutiny, as researchers have proposed different
explanations for immobility and reductions in escape behaviors (see O’Leary & Cryan, 2013, for
a review). Originally, Porsolt (as cited in O’Leary & Cryan) viewed immobility as evidence of
“behavioral despair”, indicating an inability or failure to engage in persistent escape-related
behaviors. Others propose immobility reflects a switch from an active to passive coping strategy
to dealing with an immediate stressor (Holmes, Yang, Murphy, & Crawley, 2002), which may
even have an evolutionary advantage in preserving energy for an extended exposure to a stressor.
Finally, there is also the possibility increased mobility reflects an overall reduction in swimming
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behavior, reflecting an impairment in locomotor function. Our findings rule out this last
interpretation, as both female and male KO animals were not found to differ in their exploration
of the open field apparatus, and had no apparent apraxia-type abnormalities in the gait test.
The link between neuroinflammation, cerebrovascular function, and depression are even
more apparent in older-aged populations who are particularly susceptible to vascular depression.
In this case, age-related changes in cerebrovasculature, including a leaky BBB and general
impairments in cerebral blood flow, are thought to contribute to a widespread impairment of
networks connecting cortical and subcortical structures, including the hippocampus and
entorhinal cortex, contributing to the development of a depressive condition (Taylor et al., 2013).
The current finding failed to find age-related differences in depressive behavior for IL1-R1 KO
animals. However, animals with the strongest depressive-type response during the older age of
testing on the FST were found to have a decreased vascular investment in the hippocampus.
This relationship between depressive behavior and vasculature was not found for younger
animals, consistent with an age-related change in vasculature that correlates with a depressivetype profile in older animals.
The IL1-R1 KO Mouse Phenotype
Besides the noted sex- and age-specific changes in spatial learning and memory function,
anxiety behaviors, and depressive-type behavior, IL1-R1 KO animals had generally intact
behavioral and morphogenic traits. Their locomotor behavior was within a normal range on tests
of gross motor activity and gait. IL1-R1 KO animals were found to have significantly smaller
sized eyes, but had showed no deficit in a standard rodent test of ability to use depth perception
to guide behavior, suggesting that they were not blind as a consequence. They also showed a
statistical trend toward a difference in philtrum length, but no other notable changes to facial
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morphology. The observed differences potentially reflect the importance of IL-1 in normal
neurodevelopment processes, including bone growth (MacRae et al., 2007). It is not uncommon
for children with developmental disabilities to show striking or subtle differences in facial
morphology, including smaller eyes and increased philtrum length (e.g., Korenberg et al., 1994).
While differences were observed in novelty approach and exploratory behaviors, as
discussed above in the section on anxiety, these mice were not directly tested on measures of
trait anxiety. This trait could be meaningful, as Jakovcevski, Schachner, and Morellini (2008)
found that this strain of mouse (C57BL/J6) is prone to have higher levels of trait anxiety, which
may have impacted test performance. Finally, IL1-R1 KO animals were not found to differ from
WT animals in a measure of social interactions. This finding is inconsistent with the findings of
Bison et al. (2009) who noted reduced social interactions in rats injected with LPS, although they
also observed decreases in locomotor function and other behaviors consistent with a sickness
behavior response to increased cytokine activity. Thus, social interaction test performance may
not be dependent on IL-1 activity, per se, but a more extreme sickness profile that could involve
multiple inflammatory mediators. The IL-1R1 KO animals have a very specific deficit in IL-1
signaling, and are therefore missing many components of the response induced by LPS. Our
results with animals tested at an older age may have been better indicators of any role of IL-1 in
pathological-type behaviors, because young animals normally do not have as much
neuroinflammation at baseline as older animals. Age-related increases in neuroinflammatory
drive could be reduced for IL1-R1 KO animals relative to aging WTs, making them less prone to
chronic stressors that are also associated with changes in social interaction behavior, especially
for male mice (Yee & Prendergast, 2010).
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Limitations
The current study employed the use of a KO mouse model, with behavioral tests that
were conducted across different ages, and in some case repeatedly tested with the same animals.
Given the nature of this research design, there are inherent limitations to the interpretation of the
research findings.
Behavioral testing was conducted between the ages of 2 and 13 months of age, with
animal sacrifices at approximately 14 months of age. We only observed brains of older animals
and cannot ascertain if differences in neuroanatomy were present at younger ages. This is
especially important for the interpretation of behavioral findings with younger animals.
Targeted gene modifications in animals play an important role in biomedical research,
allowing for the association of specific gene deficits with sets of behavioral outcomes. In the
case of the IL1-R1 KO mouse there is a targeted mutation that produces a strain of mouse that is
null for the production of a functional type I IL-1 receptor and therefore fails to have a normal
IL-1 component of the immune response (Glaccum et al., 1997). In the current study, adult KO
mice were compared to a set of age-matched WT animals from the same genetic background
strain, with behavioral differences attributed to the alteration of IL1-R1 activity. However, this
interpretation must be further evaluated. For example, it has been previously established that one
major complication with KO or knock-in genetic alterations is the possibility for the unintended
effects of “flanking genes” associated with genetic backcrossing (see Eisener-Dorman,
Lawrence, & Bolivar, 2009, for a review).
During the process of isolating a gene for removal, a nonfunctional gene is often
introduced to take the place of the targeted gene (Doyle, McGarry, Lee, & Lee, 2012). The
process requires the introduction of additional background material, which is later targeted for
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removal during subsequent selective breeding process, with the ultimate goal of producing a
mutant mouse strain that is identical to the original WT strain with the exception of the targeted
gene. However, there is rarely complete removal of all of the background material, which can
affect neighboring genes, with the known potential to wholly or partially affect phenotype
measures. For example, Rodrigues de Ledesma, Desaie, Bolivar, Symulu, and Faherty (2006)
were able to determine flanking genes instead of the targeted null gene were responsible for a
phenotype of reduced exploratory behavior in the B6-IL-10 KO mouse, null for IL-10 activity.
The IL1-R1 KO mouse is classified as an incipient congenic strain, reflecting an attempt to
reduce the potential for flanking genes through a specific process of inbreeding, but cannot rule
out the presence of non-targeted genetic influences (The Jackson Laboratory, 2014).
Even if mutations of a specific gene can be limited in a KO animal model, there is still an
inherent hazard regarding the outcome of behavioral data in adult animals from a targeted null
mutation. When evaluating data from adult animals, there is a temptation to assume the
differences between KO and WT animals at the time of testing is directly related to the loss of
the gene’s function in the animal at the time of testing. For example, in the current study there is
the primary interpretation that differences in performance reflect differences in IL-1 activity in
the adult animal, with less consideration of the potential impact of the loss of a normal IL1-R1
system in the development of the animal. In fact, IL-1 is known to have a widespread influence,
both in the development of muscular and skeletal systems (Alexander, Murgai, Moehle, &
Owens, 2012; MacRae et al., 2007), as well as in prenatal cortical cell migration (Ma et al.,
2014). In addition, IL-1 plays an important role in a very complex immune system that is highly
adaptable, making it likely compensatory developmental mechanisms could occur to adjust for
the reduction in normal IL-1 activity in the KO mouse. Thus, it would be ideal to compare these
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animals to animals with a normal developmental path with IL1-R1 inactivated in the adult
animal. The use of IL-1ra has been explored previously in research of IL-1 activity in rats (e.g.,
Koo & Duman, 2008) and been helpful in studying changes in behavior associated with the
blocking of IL-1 activity with the introduction of a pathogen or chronic stressor (e.g., Yirmaya et
al., 2002). The recent development of IL-1 Trap (Rilonacept) offers another method for
inhibiting IL-1 activity in an intact adult system. IL-1 Trap acts as a soluble decoy receptor, with
a very high affinity to bind to both IL-1α and IL-1β, preventing the activation of intact IL-1
receptors (Economides et al., 2002). IL-1 Trap has been found to be effective in the significant
reduction of systematic inflammation and associated symptoms, including joint pain and fatigue
(Hoffman et al., 2012). However, to date no studies have looked at cognitive behavior and the
use of IL-1 Trap in either clinical or animal research applications.
Besides concerns with interpreting the effects of gene deletion using a KO animal model,
the current study has the expected limitations of longitudinal research, including the potential for
carryover effects, including learning, across different behavioral tests and also repeated exposure
to a single behavioral test. For example, both the MWM and the FST involve swimming
behavior. While water-based testing was always separated by at least 8 weeks to try to minimize
carryover, the sequencing of testing and the frequency of testing differed for the two cohorts,
with one cohort’s first swim test being in the FST and the other cohort initially tested in the
MWM. Thus, for the cohort that was originally tested in the FST and had developed a learnedhelplessness type response in the water, helplessness may have inhibited their swimming
performance in the MWM. Likewise, animals that failed to find the platform on early training in
the MWM may have developed a learned-helplessness type response to water, affecting the
magnitude of their later response to the FST. The sequence was intentionally reversed across the
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cohorts to try to balance any potential carryover effects. However, the finding of a significant
cohort effect for the younger animals in the FST could reflect such carryover effects, as the
cohort found to have a greater learned-helplessness type response in the FST was the same
cohort that had been previously tested in the MWM. The fact that the females had successfully
learned the MWM task, and were the sex showing learned helplessness argues against amplified
helplessness, but other emotional or learning-related factors could still have contributed.
Potential learning effects may have also contributed to any noted differences in
behavioral tests administered a second time at an older age. Thus, when tested at an older age in
the MWM, animals already had prior experience and may have applied a previously learned
strategy to search for the platform in a manner that may have put them at a particular advantage
or disadvantage at the later age of testing. Attempts were made to reduce the effects of prior
learning, such as moving the platform to a different goal quadrant in the apparatus when testing
older animals. In addition, experimental controls were maintained to allow for equal advantage
across all animals, such as maintaining the locations of experiments and spatial cues within the
MWM environments for both cohorts across the younger and older testing sessions. In fact, all
groups were found to be equivalent in their latency to find the platform in the first trial of the
older aged round of testing, suggesting no genotype or sex differences in any carryover of
learning from the younger testing trials. We cannot, however, exclude the possibility of a more
delayed or gradual advantage of prior learning on the overall learning of platform location in the
older MWM test.
While controls were put in place to avoid experimenter effects, including the inclusion of
blind test administrators and scorers, and the same experimenters testing all animals for a
particular test with each cohort, other factors may have had an influence. Only one experimenter
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was available for testing both cohorts, with a different set of assistant experimenters for each
cohort. Thus, this could have contributed to any observed cohort effects. In addition, the sex of
experimenters was not controlled, with a mix of male and female experimenters for different
behavioral tests. Recently, it has been noted mice may respond differently to male and female
experimenters, with a heightened stress response when handled by men (Sorge et al., 2014).
Lastly, spatial learning in the MWM is enhanced by the ability to use visual spatial cues,
and we cannot rule out the possibility of preferentially impaired vision for the IL1-R1 KO
animals. While KO animals were not found to differ from WT animals on a gross measure of
depth perception, they did have slightly smaller eyes. However, given that mice rely heavily on
non-visual spatial cues, and that most inbred mice have poor vision by middle age in any case, it
is unlikely any potential visual impairment had any significant impact on maze performance. It
is important to note that both male and female KO animals had small eyes, yet only the males
were found to have significant learning impairments in the MWM at a young age.
General Conclusion and Future Directions
The current study provides a behavioral phenotype for the IL1-R1 KO mouse, revealing a pattern
of changes in cognitive and emotional behaviors that vary with age and by sex. Overall effects
of impaired spatial learning and memory performance were observed, but were primarily driven
by very poor performance for male IL1-R1 KO mice. In addition, reduced anxiety effects were
observed, again stronger for male than female animals. These findings are important in
understanding the impact of IL-1, and the neuroimmunological system as a whole on normal
cognitive and emotional functioning. The findings also elucidate the importance of the inclusion
of female animals in animal research, with sex-based differences that may reflect both biological
and environmental factors that differentially effect vulnerability to the development of cognitive
and emotional disorders. The current study is also potentially illuminating for understanding the
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impact of IL-1 in aging populations, in which neuroinflammation is a known concern and is
often associated with cerebrovascular disease, vascular depression, and Alzheimer’s disease.
Future research should focus in on the observed sex and genotype effects in IL1-R1 KO animals,
and the potential interaction of these two factors, particularly exploring different models of
depression and anxiety and looking into differences that may be observed for acute versus
chronic stressors. Given the potential for age and sex to play a role, these data provide some
rationale for exploring possibilities for a protective function of moderate levels of IL-1 activity in
the regulation emotional behaviors, and/or sex-related hormones that may help to prevent the
cognitive and emotional impairments associated with normal aging, Alzheimer’s disease, and
vascular depression.
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Appendix B
Animal Ages for Each Behavioral Test

Animal ages at times of testing for behavioral tests reviewed in AIM 1 and AIM 2. Tests
administered at two different ages for AIM 2 are listed in table as Time 1 (younger animals) and
Time 2 (older animals).

Behavioral Test
Elevated Plus Maze
Facial Morphometrics
Gait
Light-Dark Exploration (younger)
Light-Dark Exploration (older)
MWM (younger)
MWM (older)
Novelty-Suppressed Feeding
Object Placement
Open Field
FST (younger)
FST (older)
Social Interaction
Visual Cliff
Y-Maze
- test not administered

Age (in months)
Cohort 1 Cohort 2
5
11
2
5
2
5
4
12
3
5
12
11
13
13
11
13
11
5
2
13
7
7
5
6
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